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I. Summary 
At the request of concerned residents, the Community Assessment Program (CAP) at the 
Massachusetts Department of Public Health (MDPH), Bureau of Environmental Health 
(BEH), conducted an evaluation of three state-regulated former industrial sites and cancer 
incidence for the city of Methuen. This evaluation was initiated because of community 
concerns about a suspected increase in the overall incidence of brain cancer and 
childhood cancer (individuals aged 19 and under at diagnosis) among individuals living 
near three former industrial sites at 4 Gleason Street, 254 Broadway, and 54 Osgood 
Street in central Methuen. Two of the sites, 4 Gleason Street and 254 Broadway, were 
industrial sites in central Methuen dating back to the mid-1800s. The third site, 54 
Osgood Street, was the scene of a fire that destroyed a building housing hazardous 
material.  
Environmental contamination associated with the three sites in central Methuen of 
concern to some residents was evaluated for the potential of exposure to nearby residents 
and subsequent health risks. The evaluation found the opportunities for exposure to 
contaminants to be limited. The groundwater in this area was not and is not used as a 
source of drinking water. No increased risks of cancer or other adverse health effects 
were predicted assuming a nearby resident regularly came into contact with the maximum 
detected concentrations of contaminants in the soil, sediment or surface water at the three 
sites. The three sites have been remediated, are currently vacant, and access to them is 
limited. 
In response to community concerns, the CAP evaluated the incidence of brain cancer and 
childhood cancer in the city of Methuen and compared it to the incidence in the state of 
Massachusetts as a whole. To evaluate patterns or trends over time, cancer incidence 
rates were calculated over three time periods: 1982-1988, 1989-1995, and 1996-2002. 
Community members also expressed concern about different types of non-cancer 
illnesses among Methuen residents. Along with the initial written request for a review of 
cancer incidence, the CAP was provided with 11 surveys that had been completed by 
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residents of the Gleason Street neighborhood in Methuen. The CAP reviewed hospital 
discharge data on the number of asthma-related hospitalizations in the city of Methuen in 
response to concerns about respiratory impacts from the three sites. New data on pediatric 
asthma that have become available through an environmental public health tracking 
initiative at the BEH were also utilized to respond to resident concerns. 
At the citywide level, the incidence of brain cancer was elevated for three time periods 
(1982-1988, 1989-1995 and 1996-2002). None of the elevations were statistically 
significant, meaning that chance or random fluctuation cannot be ruled out as a reason for 
the increased incidence. At the census tract (CT) level, no single CT had a consistently 
elevated incidence of brain cancer over the three time periods that was statistically 
significant. For all three time periods, the incidence of childhood cancer occurred about 
as expected in the city of Methuen with one exception.  During 1996-2002, four children 
were diagnosed with cancer in CT 2523 in central Methuen when approximately one 
would be expected. Three of the four children were diagnosed with brain cancer.  Their 
ages at diagnosis and cancer subtypes were consistent with what would be expected.  One 
additional child has been diagnosed with brain cancer in this CT since 2003.   
In addition to evaluating time trends, the geographic distribution of residence at diagnosis 
for those individuals diagnosed with brain cancer or childhood cancer in Methuen was 
evaluated to determine if any atypical spatial patterns existed. With one exception, the 
review of the geographic distribution of cancer for the years 1982–2002 did not reveal 
any unusual spatial patterns or concentrations of diagnoses at the neighborhood level. 
During the 1996-2002 time period, two of the three children diagnosed with brain cancer 
lived in close proximity to each other.  As discussed in Section IV, the opportunity for 
exposure to environmental contaminants was determined to be limited.  No increased risk 
of cancer or other adverse effects was likely even if a nearby resident was exposed 
regularly to the maximum detected concentrations of soil, sediment, or surface water 
contaminants.  Analysis of risk factor information (for example, age, gender, smoking 
history, and occupation) for individuals diagnosed with brain cancer suggested that the 
trends observed in Methuen are similar to those seen in the general population. For these 
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reasons, it does not appear that a common factor (environmental or non-environmental) is 
related to these brain cancer diagnoses. 
Based on criteria established by ATSDR, the 54 Osgood Street site is classified as posing 
no apparent public health hazard to the public in the past, present and future. Since 
contaminants detected in groundwater at the 4 Gleason Street and 254 Broadway sites 
could be drawn into potential future private wells, these sites would pose a public health 
hazard in the future should wells be installed in contaminated groundwater areas. 
II. Introduction 
At the request of concerned residents, the Community Assessment Program (CAP) at the 
Massachusetts Department of Public Health (MDPH), Bureau of Environmental Health 
(BEH), conducted an evaluation of three state-regulated former industrial sites and cancer 
incidence for the city of Methuen. This evaluation was initiated because of community 
concerns about a suspected increase in the overall incidence of brain cancer and 
childhood cancer (individuals aged 19 and under at diagnosis) among individuals living 
in the area of three former industrial sites at 4 Gleason Street, 254 Broadway, and 54 
Osgood Street in central Methuen (see Figure 1). Two of the sites, 4 Gleason Street and 
254 Broadway, were industrial sites in central Methuen dating back to the mid-1800s. 
The third site, 54 Osgood Street, was the scene of a fire that destroyed a building housing 
hazardous material. In order to address these community concerns, the MDPH reviewed 
available environmental data for the three sites and considered potential ways that people 
may come into contact with contaminants detected in groundwater, soil, surface water, 
and sediment located on or near the sites.   
This investigation also reviewed the incidence of brain cancer and childhood cancer in 
the city of Methuen and compared it to the incidence in the state of Massachusetts as a 
whole. Additionally, available information about risk factors, including environmental 
factors, related to the development of these cancers was evaluated. The city of Methuen is 
divided into 11 smaller geographic areas, or census tracts. Cancer incidence rates were 
also evaluated for each census tract with a particular focus on CT 2523, where the three 
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former industrial sites of concern are located, and the two adjacent CTs of 2524 and 
2525.02 (see Figure 2). Cancer incidence data for Methuen were obtained from the 
Massachusetts Cancer Registry (MCR). At the time of this evaluation, the most recent 
and complete cancer incidence data available from the MCR were through the year 2002. 
Three time periods (1982-1988, 1989-1995 and 1996-2002) were examined to assess 
possible trends over time. 
In addition to the calculation of cancer incidence rates, a qualitative analysis of the 
geographic distribution of residents of Methuen diagnosed with brain cancer (both adults 
and children) or childhood cancer was conducted by mapping their residence at the time 
of diagnosis. This was done to determine if any spatial patterns existed in a particular 
area of the city or in relation to the three sites at 4 Gleason Street, 254 Broadway, and 54 
Osgood Street. 
Finally, community members also expressed concern about different types of non-cancer 
illnesses among Methuen residents. Along with the initial written request for a review of 
cancer incidence, the CAP was provided with 11 surveys that had been completed by 
residents of the Gleason Street neighborhood in Methuen. The survey, designed by a 
resident of Methuen, asked individuals to report on any illnesses they had been diagnosed 
with, along with other personal and residential history information. For that reason, this 
report also contains a qualitative review of the information contained in these surveys. In 
addition, the CAP also reviewed hospital discharge data on the number of asthma-related 
hospitalizations in the city of Methuen in response to concerns about respiratory impacts 
from the three sites of concern. These data are collected by the Massachusetts Division of 
Health Care Finance & Policy and are available through the Massachusetts Community 
Health Information Profile (Mass CHIP).  New data that have become available through 
an environmental public health tracking initiative at the BEH were also utilized.   
III. Objectives 
The specific objectives of this investigation were as follows: 
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•	 To review the incidence of brain cancer among all ages and childhood cancer in the 
city of Methuen and at the smaller geographic level of the census tract, with a 
particular focus on central Methuen. 
•	 To evaluate the geographic distribution of individuals diagnosed with these cancer 
types in Methuen, to see if there are any patterns in particular areas of the town or in 
the areas of potential environmental concern. 
•	 To review descriptive information available from the MCR for individuals diagnosed 
with brain cancer and childhood cancer in Methuen, to see if there are any particular 
characteristics related to known or suspected risk factors, including environmental 
factors, for developing these diseases. 
•	 To discuss possible exposures related to three former industrial sites in the context of 
the available scientific and medical literature on cancer and contaminants of concern 
to determine whether further investigation or public health action is warranted. 
•	 To assess the number of asthma-related hospitalizations in the city of Methuen. 
•	 To review and evaluate 11 surveys provided to the CAP by residents of Methuen who 
had reportedly been diagnosed with various immunological diseases. 
IV. Community Environmental Concerns 
Introduction 
Some members of the Methuen community have expressed concerns about odors and 
possible contamination of the soil and groundwater in the area of three former industrial 
or manufacturing sites located in the center of Methuen: 4 Gleason Street, 254 Broadway, 
and 54 Osgood Street. In order to address these community concerns, the MDPH 
contacted the Massachusetts Department of Environmental Protection (MDEP) as well as 
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the United States Environmental Protection Agency (EPA) to obtain and review available 
environmental information pertaining to these sites. Environmental sampling data were 
available for groundwater, soil, surface water, and sediment located on or in the vicinity 
of the sites. Available environmental sampling data were reviewed, and a screening 
evaluation was conducted to identify those substances that may need to be considered for 
further analysis, to determine whether they may be of potential health concern to 
residents. The screening analysis identified maximum concentrations of contaminants 
detected in various types of environmental media (i.e., soil and water) and compared 
these concentrations to health-based comparison values. Comparison values are set well 
below levels that are known or anticipated to result in adverse health effects. 
Contaminant concentrations that exceed comparison values will not necessarily affect 
one’s health. If a comparison value was not available for a specific contaminant, the 
maximum detected concentration was compared to Risk-Based Concentrations (RBCs) 
developed by the United States EPA Region III (USEPA 2006a), Preliminary 
Remediation Goals (PRGs) developed by the United States EPA Region 9 (USEPA 
2004), or the applicable groundwater and soil standards developed by MDEP (MDEP 
2006a), in that order. For contaminants detected in groundwater, maximum 
concentrations were also compared with state and/or federal drinking water standards. An 
evaluation of potential exposure pathways was conducted to determine whether 
contamination identified at the industrial sites in the Gleason Street neighborhood could 
be impacting the health of nearby residents of Methuen in the past, present, or future. 
For each site discussed below, background information on the history of the site is 
provided followed by discussion of the status of each site within MDEP’s site 
investigation and cleanup process. An evaluation of the potential for exposure of 
Methuen residents to site-related contamination is provided, and finally, the available 
environmental data are compared to health-based screening values to determine whether 
there may be potential health impacts to residents. 
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A. 4 Gleason Street 
Background 
The property located at 4 Gleason Street, Methuen, is approximately 3.7 acres in size and 
is located on a dead end street that runs east/west between Broadway and the Spicket 
River in central Methuen (see Figure 1). The parcel of land currently consists of a 
building footprint where the building was razed, a paved area surrounding the building 
footprint, with the remainder of the lot being unpaved land that is adjacent to the Spicket 
River. The building was recently demolished and portions of the property have remained 
fenced off from the public since demolition (LFR 2003). 
The site was used by various industries since the mid-19th century. Historical use of the 
property included a textile mill, wet wash laundry, semi-conductor manufacturing and 
manufacturing of metal cabinets for computers. Industrial activities at this site ceased in 
the late 1990s (LFR 2003). After being unused for several years, current plans reportedly 
include redevelopment of the property (along with the adjacent property at 254 
Broadway) into assisted living apartments for the elderly. The site was excavated and 
cleaned up in preparation for construction in 2005.  
MDEP 21E Releases 
In 1983, the Massachusetts Legislature established a statewide hazardous waste site 
cleanup program (the state equivalent of the federal Superfund program) under Chapter 
21E of Massachusetts General Laws (M.G.L. c21E, 310 CRM 40.0000). Under this 
legislation, the MDEP enforces regulations governing the investigation and cleanup of 
hazardous material and oil release sites, known as “21E sites,” in the Commonwealth. 
The 21E sites are characterized by one or more releases of oil or other hazardous 
material. Releases can result from a variety of sources, including trucks and other 
vehicles, underground storage tanks, and aboveground storage drums. Releases vary 
widely with respect to materials involved, the relative amount of materials released, and 
the geographic extent of contamination. Depending on the relative severity of the release, 
the deadline for reporting a release to MDEP is 2 hours, 72 hours, or 120 days. 
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The MDEP Bureau of Waste Site Cleanup has information on these hazardous material 
and oil releases, including assessment and remedial response measures, beginning in 
1977 to the present; however, records prior to 1984 are known to contain significant data 
gaps (MDEP 2006b). MDPH obtained the most recent information regarding all 
hazardous material and/or oil releases located at 4 Gleason Street, Methuen. The 
information indicates that three known releases were reported at the site. Releases of oil 
were reported on July 15, 1991, and September 22, 2005. A release of oil and hazardous 
material was reported on July 6, 2004. Release abatement measures were conducted in 
response to the 1991 release and a completion report was submitted to MDEP. In 2005, 
during the removal of sewer lines at the 4 Gleason Street site, petroleum-impacted soils 
were discovered and required MDEP notification (LFR 2006a). These contaminated soils 
were likely linked to an underground storage tank (UST) containing heating oil that was 
discovered following detection of the petroleum-impacted soils (LFR 2006a). An 
Immediate Response Action (IRA) was taken and the UST, as well as contaminated soil 
around the tank, were excavated, removed from the site, and disposed of at proper 
facilities (LFR 2006a). 
Releases in 2004 and 2005 have been classified as having a Class A-2 Response Action 
Outcome (RAO), indicating that remedial work was completed, a permanent solution has 
been achieved and, although contamination has not yet been reduced to background 
levels, a level of “no significant risk” of harm to health, safety, public welfare and the 
environment has been achieved (MDEP 1995a, MDEP 2006c). 
Environmental Data and Exposure Pathway Analysis 
To address community concerns about possible environmental exposures associated with 
the property at 4 Gleason Street, MDPH reviewed information on file with MDEP and 
EPA. The MDEP has recently reviewed and analyzed the data from the numerous 
environmental investigations that have been conducted by different Licensed Site 
Professionals (LSPs). Sampling data have been produced by Clean Harbors 
Environmental (CHE) (1986-1993), TRC (2000) and LFR Levine-Fricke (2002-present), 
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from their work conducted at the site (CHE 1995, TRC 2000, LFR 2005, LFR 2006a). 
Environmental sampling data were available for groundwater, soil, surface water, and 
sediment located on or in the vicinity of the site. Available environmental sampling data 
were reviewed, and a screening evaluation was conducted to identify those substances 
that may need to be considered for further analysis to determine whether they may have 
the potential to impact the health of residents. 
Hazardous material and oil releases are potential sources of exposure to contamination. It 
is not possible to determine whether individuals residing in the area were actually 
exposed to contaminants without detailed information about contaminant movement 
through the environment, the population at risk of exposure, a location of actual human 
contact with the contaminant, and evidence that the contaminant actually entered the 
body of persons at risk of exposure through ingestion, dermal absorption, or inhalation. 
However, the pattern of cancer in Methuen residents was reviewed in relation to these 
potential sources of environmental exposures and is discussed in Section V. 
Groundwater 
According to MASSGIS, a web-based geographical information system, there are no 
community drinking water wells or MDEP Zone II protection areas within 1 mile of the 
site. A Zone II protection area is defined as the area of an aquifer which contributes water 
to a well under the most severe pumping recharge conditions that can be realistically 
anticipated (MDEP 1995a). The nearest medium yield, potentially productive aquifer is 
approximately ¾ of a mile northwest of the site, while the nearest high yield, potentially 
productive aquifer is located over 1 mile northwest of the site. The nearest Interim 
Wellhead Protection Area (IWPA) is also located over 1 mile from the site. Due to these 
conditions, it is unlikely that groundwater in the vicinity of 4 Gleason Street could be 
used as a source of drinking water. 
There are currently many monitoring wells on the 4 Gleason Street property that have 
been used to collect groundwater samples since 1986. These wells are used solely to 
monitor groundwater near the property and are not used for any other drinking or non­
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drinking water purposes. The locations of these groundwater monitoring wells are 
depicted in Figure 3. 
The monitoring wells around the property had detected concentrations of some volatile 
organic compounds (VOCs) and metals. The highest levels of contaminants measured in 
groundwater on the entire site were compared to health-based drinking water comparison 
values to help determine if further evaluation was necessary. These health-based 
comparison values are set well below levels that are known or anticipated to result in 
adverse health effects. Contaminant concentrations that exceed comparison values will 
not necessarily affect one’s health. Of the contaminants detected in monitoring wells at 
the 4 Gleason Street property, fourteen required further evaluation. Table 1 summarizes 
the maximum concentrations of each of these contaminants as well as their comparison 
values. 
Exposure to these contaminants in groundwater is unlikely since groundwater in the 
vicinity of 4 Gleason Street and surrounding industrial sites of community concern is not 
a source of drinking water for Methuen residents. Information reviewed indicated that 
there are no registered or known drinking water supply wells within a 1-mile radius of the 
site (CHE 1994). The City of Methuen obtains its drinking water from the Merrimac 
River and then treats and tests this water at the Burnham Road Water Treatment Plant to 
ensure that it meets state and federal standards for safe drinking water (MWD 2006). 
Since there is no official moratorium in place to restrict the installation of new private 
wells in the city of Methuen, future exposure to contaminants identified at 4 Gleason 
Street is possible if new private drinking water wells are installed in the path of 
contaminated groundwater, which flows in an easterly and southeasterly direction (CHE 
1995). If nearby residents were to ingest contaminated groundwater in the future at 
concentrations detected in onsite monitoring wells, non-cancer and cancer health impacts 
could be possible due to exposure to some metals and VOCs. 
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Soil 
Samples of soils and sediment around the 4 Gleason Street property contained detectable 
levels of VOCs, semi-volatile organic compounds (SVOCs), polycyclic aromatic 
hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and metals. The highest levels 
measured in soils on the entire site were compared to health-based comparison values to 
help determine if further evaluation is necessary. As with screening values for 
groundwater, contaminant concentrations that exceed comparison values in soils will not 
necessarily affect one’s health. A majority of contaminants were below health-based 
comparison values and are not expected to result in adverse health impacts. However, 
nine contaminants, including one VOC, one petroleum hydrocarbon fraction, some PAHs 
and some metals, required further evaluation. It is important to note that the maximum 
concentrations of these nine contaminants were measured during sampling events in 
1992-1993 and 2000 and all are located in areas that were excavated in 2005. Table 2 
summarizes the maximum concentrations of each of these chemicals as well as their 
comparison values.  
Prior to excavation and cleanup in 2005, it is possible that an older child playing onsite at 
4 Gleason Street could have been exposed through incidental ingestion of or dermal 
contact with contaminants such as trichloroethene, benzo(a)pyrene, arsenic, and 
chromium detected in onsite surface soil at levels above comparison values. However, it 
is important to consider that comparison values are based on a residential exposure 
scenario, and it is unlikely that a child playing at the site infrequently would have had 
contact with onsite surface soil for a comparable frequency and duration of time. 
Although the area sampled is a former industrial site, it is possible that an older child 
could have visited the site and had infrequent contact with the soil. Assuming the child 
inadvertently ingested 200 milligrams of surface soil containing the maximum 
concentration of any of the above listed contaminants detected on the site for 2 days 
every week for 22 weeks (May through September, the warmer months of the year) over 
12 years, the exposure would not be expected to result in an increased cancer risk. Also, 
under the same exposure conditions described above, the level would be below the 
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ATSDR Minimal Risk Level (MRL). The MRL is an estimate of daily exposure to a 
contaminant below which non-cancer, adverse health outcomes are unlikely to occur. 
Since the exposure dose for an older child playing onsite is below the MRL, non-cancer 
health effects would also not be expected. 
Present and future exposure to contaminants in soil is unlikely since areas with the 
highest levels of contaminants were excavated and removed in 2005. Prior to demolition, 
the eastern portion of the building contained a former boiler room and elevated PAH 
levels in soil were suspected to be from ash left from coal burning (LFR 2006a). 
According to ATSDR toxicological reports, PAHs can be formed during incomplete 
burning of coal, oil, gas, wood, garbage, or other organic substances such as tobacco and 
charbroiled meat. Elevated levels of PAHs can be found in the environment as a result of 
forest fires, residential wood burning and exhaust from automobiles or trucks (ATSDR 
1995). Following excavation, confirmatory soil sampling indicated that a majority of the 
elevated PAH concentrations in the area were reduced to background levels or were not 
detected. Chromium levels also decreased to a range of 11-33 parts per million (ppm) 
following excavation and were both below comparison values and within the range of 
typical soil background levels for chromium (1-1,000 ppm) (USGS 1984). Arsenic levels, 
too, were brought within the range of typical soil background levels. Areas containing 
high levels of trichloroethene were also excavated and levels were significantly reduced 
(LFR 2006a). All excavated soil was temporarily stored on the property while awaiting 
removal and disposal at disposal/reuse facilities (LFR 2006a). 
Surface Water 
The largest surface water body bordering the site is the Spicket River, which runs along 
the perimeter of the 4 Gleason Street property to the west and flows in a southeasterly 
direction until it joins the Merrimac River. Surface water from the Spicket River was 
sampled by CHE in 1991-1992 and some metals were detected (MDEP 2005). The 
highest levels measured in surface water were compared to drinking water comparison 
values to help determine if further evaluation was necessary. Because health-based 
comparison values for surface water do not exist, drinking water comparison values were 
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used as screening values. Comparison values are set well below levels that are known or 
anticipated to result in adverse health effects. Additionally, the use of drinking water 
comparison values to screen surface water is conservative (i.e., health-protective) because 
drinking water values assume that an individual ingests 2 liters per day of the water. 
Since it is unlikely that an individual would ingest 2 liters of surface water each day, 
exposure to contaminants found in surface water is considerably less than exposure to 
contaminants found in drinking water. Comparison values do not predict adverse health 
effects and contaminants concentrations that exceed comparison values will not 
necessarily affect one’s health. 
Of the contaminants detected in surface water near 4 Gleason Street, only cadmium and 
lead exceeded the drinking water comparison values. Individuals living near the 4 
Gleason Street property would likely be exposed less frequently to contaminated surface 
water in the Spicket River through incidental ingestion and dermal contact than to 
drinking water. For example, while cadmium and lead were detected above the drinking 
water comparison value, calculations made using assumptions specific to surface water 
ingestion show that this concentration is not expected to produce adverse health effects in 
adult or child residents playing near the Spicket River.  
Exposure to these contaminants for residents in the surrounding neighborhoods would be 
very limited. Water from the Spicket River is not incorporated into the drinking water for 
Methuen and residents would have limited exposure to the river. The location where the 
Spicket River joins the Merrimac River is approximately 3 miles downstream from where 
the city of Methuen obtains its drinking water (MWD 2005). Therefore, residents of 
Methuen would not be consuming water from the Spicket River as part of their drinking 
water. 
Sediment 
Spicket River sediment along the edge of the 4 Gleason Street property was sampled in 
2000 by TRC. The highest levels measured in the sediment were compared to health-
based comparison values to help determine if further evaluation is necessary. Since 
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comparison values for sediment do not exist, soil comparison values were used as 
screening values. All detected contaminants were below comparison values and within 
the range of typical background levels of metals in soil (USGS 1984). Therefore, 
exposure to sediment from the Spicket River on the 4 Gleason Street property is not 
expected to result in adverse health effects for residents. 
Site Status 
As stated above, release abatement measures were conducted in response to the 1991 
release and a completion report was submitted to MDEP. In addition, releases in 2004 
and 2005 have been classified as having a Class A-2 RAO, indicating that remedial work 
was completed, a permanent solution has been achieved and, although contamination at 
the property has not yet been reduced to background levels, a level of “no significant 
risk” of harm to health, safety, public welfare and the environment has been achieved 
(MDEP 1995a, MDEP 2006c). 
B. 254 Broadway 
Background 
The property located at 254 Broadway, Methuen, is approximately a quarter acre in size 
and is located adjacent to the 4 Gleason Street property. A former service station and 
garage building which once stood on the site were demolished in 2005. Currently the lot 
remains undeveloped and vacant. Properties surrounding 254 Broadway consist of mixed 
retail and commercial office spaces. 
From the 1880s until the early 1930s, this property housed textile manufacturing 
facilities, including a knitted fabric company, a hat manufacturer, and a worsted good 
manufacturer. In the mid-1930s, the property was converted to a gas station/automobile 
repair shop. For the next several decades the ownership changed hands numerous times, 
although the fundamental business as a gas station/automobile repair shop remained 
constant (LFR 2004). In 1986, the Methuen Fire Department asked the owner at the time 
to remove underground storage tanks (USTs) from the property that were no longer in 
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use. The USTs were removed from the ground, and from that time forward, the business 
was strictly an automobile repair shop (Enstrat 1998). 
MDEP 21E Releases 
The MDEP Bureau of Waste Site Cleanup has information on hazardous material and oil 
releases, including assessment and remedial response measures, for 1977 to the present; 
however as mentioned, records prior to 1984 are known to contain significant data gaps 
(MDEP 2006b). MDPH obtained the most recent information regarding all hazardous 
material and/or oil releases located at 254 Broadway, Methuen. The only known release 
reported at the site was discovered in 2000 as a result of environmental testing and 
assessment being conducted by TRC on behalf of a new property owner (LFR 2006b). 
Environmental testing conducted during UST system removal and in conjunction with 
testing done by TRC at the adjacent 4 Gleason Street site showed elevated levels of 
volatile petroleum hydrocarbons (VPHs) at the site. Under Chapter 21E of Massachusetts 
General Laws (M.G.L c21E, 310 CRM 40.0000), this release required reporting to the 
MDEP within 120 days. The 120-day reports are releases thought unlikely to result in 
human exposure to contaminants. The release was likely related to the UST tank system 
that existed during historical gas station and auto repair shop activities and information 
reviewed indicates that no other USTs are known to be present onsite (LFR 2006b).  
Environmental Data and Exposure Pathway Analysis 
To address concerns about possible environmental exposures associated with the property 
at 254 Broadway, MDPH reviewed information on file with MDEP and EPA. 
Environmental sampling data were available for water and soils located onsite. Available 
environmental sampling data were reviewed, and a screening evaluation was conducted 
to identify those substances that may need to be considered for further analysis to 
determine whether they may be of potential health concern to residents. As mentioned, 
the screening analysis identifies maximum concentrations of contaminants detected in 
various types of environmental media (i.e., soil and water) and compares these 
concentrations to health-based comparison values. Comparison values are set well below 
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levels that are known or anticipated to result in adverse health effects. Contaminant 
concentrations that exceed comparison values will not necessarily affect one’s health. 
The most recent groundwater monitoring data available were obtained during sampling 
events in 2002 (August) and 2005 (February, April, November). Groundwater from seven 
monitoring wells located throughout the site was analyzed for metals, VOCs, and 
petroleum hydrocarbon fractions. Metals were not detected onsite, however some VOCs 
and petroleum hydrocarbon fractions were detected at elevated levels.  
Of all the contaminants detected in groundwater at 254 Broadway, four chemicals 
exceeded health-based comparison values and therefore required further evaluation in this 
report. These four chemicals are C5-C8 Aliphatics Hydrocarbons, C9-C10 Aromatic 
Hydrocarbons, toluene, and naphthalene. The maximum concentration of each of these 
four chemicals was detected at monitoring well MW-3, which is located within the area 
of the former UST. Table 3 summarizes the maximum concentrations of each of these 
chemicals as well as their comparison values. 
Present exposure to these contaminants in groundwater is unlikely since groundwater in 
the vicinity of 254 Broadway and surrounding industrial sites of community concern is 
not a source of drinking water for Methuen residents. The groundwater wells sampled at 
254 Broadway are for monitoring purposes only, these wells are not used for any other 
drinking or non-drinking water purposes. Currently, the ingestion of groundwater is not a 
potential pathway because there are no public or private drinking water supply wells 
within a 1- mile radius (CHE 1994). As previously discussed, the City of Methuen 
obtains its drinking water from the Merrimac River and then treats and tests this water at 
the Burnham Road Water Treatment Plant to ensure that it meets state and federal 
standards for safe drinking water (MWD 2006). 
Exposure to contaminants identified at 254 Broadway could be possible if new private 
drinking water wells are installed in the path of contaminated groundwater, which flows 
south toward the Spicket River (LFR 2006b). If nearby residents were to ingest 
16
 
contaminated groundwater in the future at concentrations detected in onsite monitoring 
wells, non-cancer health impacts are possible due to exposure to some petroleum 
hydrocarbon fractions and toluene. 
Soil monitoring data were also available for the 254 Broadway property. Soil sampled 
during 2002 indicated elevated levels of some contaminants found in the area of the 
former USTs and gas pump island, which is expected given the background of the 
property and location of USTs (Enstrat 1998, TRC 2001, LFR 2006b). In August and 
September 2005, the contaminated soil was excavated from the former UST area (LFR 
2006b). The soil was excavated to a depth of approximately 8 to 12 feet below ground 
surface and a total of 113 cubic yards of soil was removed. However, confirmatory 
sampling indicated that contamination remained in a small area. Soil was again excavated 
to a depth of approximately 10 to 12 feet, and an additional 44 cubic yards was removed 
from the site. Additional soil sampling was conducted following this excavation and 
showed that prior detected contamination had been removed. The limited nature of the 
contamination and particularly the subsurface location, a depth of over 10 feet below the 
ground surface, would make it unlikely for nearby residents to have been exposed to the 
contaminants in the past. Remediation activities conducted in 2005 eliminate present and 
future opportunities for nearby residents to be exposed to these contaminants. Therefore, 
soil on the 254 Broadway site is not expected to result in increased cancer risks nor 
increased non-cancer health impacts to residents in the surrounding neighborhood.  
Site Status 
On June 14, 2006, LFR submitted a Release Abatement Measure (RAM) Completion 
Report and Class A-2 RAO for the property located at 254 Broadway (LFR 2006b). A 
Class A-2 RAO indicates that remedial work was completed, a permanent solution has 
been achieved and, although contamination has not yet been reduced to background 
levels, a level of “no significant risk” has been achieved (MDEP 1995a, MDEP 2006c).  
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C. 54 Osgood Street 
Background 
The property located at 54 Osgood Street is near the intersection of River Street and 
Osgood Street in central Methuen (see Figure 1). Prior to a fire in January 1994, the site 
housed a metal plating business that operated for approximately 20 years (MDEP 1995b). 
The site is currently vacant and is bordered by commercial properties such as a restaurant 
and an office building. 
As stated above, the MDEP Bureau of Waste Site Cleanup has information on hazardous 
material and oil releases, including assessment and remedial response measures, for 1977 
to the present; however, records prior to 1984 are known to contain significant data gaps 
(MDEP 2006b). MDPH obtained the most recent information regarding all hazardous 
material and/or oil releases located at 54 Osgood Street, Methuen. The only known 
release reported at the site was reported on January 15, 1994 and coincides with a fire 
that destroyed the building. Prior to the fire, metal plating operations had ceased at the 
site, and approximately 49 55-gallon drums of hazardous materials were stored in the 
building (Weston 1994). The site inventory of hazardous materials present at the time of 
the fire is attached as Appendix A. Under Chapter 21E of Massachusetts General Laws 
(M.G.L c21E, 310 CRM 40.0000), this release required reporting to the MDEP within 2 
hours, upon which time immediate action was taken. The Methuen Fire Department 
(MFD) let the fire burn until an MDEP response team could assess the possible 
environmental impacts of the fire and any subsequent firefighting activities. Upon arrival 
at the site, the response team assessed the potential environmental impacts from the fire. 
Two conditions were of concern: the water runoff from firefighting activities and the 
danger of the smoke plume emanating from the fire. The response team determined that 
sand dikes were needed to immediately contain the runoff. The contained runoff was then 
collected in vacuum trucks to prevent accumulation and the possible leaching of 
contaminants into the surrounding soil or water (the Spicket River is within a ¼ mile of 
the 54 Osgood Street property). The runoff was shipped to a licensed disposal site for 
appropriate disposal. Once the plans for collection of the runoff were in place, the MFD 
began to extinguish the fire (Weston 1994). 
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With the runoff water contained, the apparent immediate environmental impact from this 
fire was potential impacts to residents from the smoke plume created by the fire. Air 
monitoring was conducted initially by the Massachusetts District 6 Haverhill Hazardous 
Materials Team (HMT), who determined that hydrogen sulfide, hydrogen cyanide, sulfur 
dioxide, and benzene were not present in the smoke plume (Weston 1994). Air 
monitoring was then conducted by members of the MDEP response team to further assess 
contaminants in the smoke plume (See next section for further discussion).  
Once the immediate response to the fire was complete, the MDEP sought to ensure that 
the site was neither a short-term nor a long-term hazard to the residents of Methuen. 
Immediately after the fire, an 8-foot chain-link fence was constructed to limit access to 
the property and any potential onsite contamination. Security was also provided to 
prevent site access during the night. During clean-up activities, the building debris was 
tested for contamination. Any contaminated material was disposed of accordingly and 
regular waste was removed from the site as well (MDEP 1995b). 
After completing the removal of the building debris, testing was conducted on the site 
and surrounding properties, to determine the need for further remediation work on the 
site. Soil sampling performed by the MDEP did not reveal any environmental impact to 
the soil in the area. In early 1995, the immediate response action was considered 
complete and no further action was deemed necessary (MDEP 1995c). 
Environmental Data and Exposure Pathway Analysis 
To address concerns about possible environmental exposures associated with the property 
at 54 Osgood Street, MDPH reviewed and analyzed information on file with MDEP. 
Environmental sampling data were available for runoff water that resulted from 
firefighting activities as well as for air and soils located onsite. Available environmental 
sampling data for the runoff water and air were reviewed and evaluated qualitatively. 
Environmental sampling data for soil were reviewed, and a screening evaluation was 
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conducted to identify those substances that may need to be considered for further analysis 
to determine whether they may be of potential health concern to residents.  
Initial air monitoring data performed by the HMT were not available, but discussion in 
Weston (1994) indicated that hydrogen sulfide, hydrogen cyanide, sulfur dioxide, and 
benzene were not detected in the smoke plume at 54 Osgood Street. Additional air 
monitoring data showed that levels of radiation as well as hydrogen cyanide, hydrogen 
sulfide, and chlorine were not detected during MDEP response team air monitoring 
(Weston 1994). In addition, the data show that while contaminant levels in air close to the 
building were elevated, levels as close as 50 feet downwind of the building were similar 
to background levels (Weston 1994). 
Soil sampling was conducted on December 1, 1994, to determine if contaminants from 
the site had impacted nearby properties. The highest levels of contaminants measured in 
soil at each nearby property were compared to health-based comparison values for soil to 
help determine if further evaluation is necessary. Levels of contaminants such as lead, 
nickel, and zinc measured at nearby properties were all below health-based comparison 
values and were not expected to result in a health threat to community residents. Copper 
levels in the area of the Spicket River were found to be above comparison values and 
required further evaluation. 
An evaluation of potential exposure pathways was conducted to determine whether 
contamination identified at the 54 Osgood Street site could be impacting nearby residents 
of Methuen in the past, present, or future. Fugitive or stack air emissions may have 
possibly occurred at the site while the facility was in operation; however, there are no 
data relative to past operations at the site. Since a review of available information did not 
find any historical record of hazardous materials being released at the site, exposure to 
the hazardous materials prior to the fire on the site would probably have occurred among 
individuals who worked in the building. During and immediately following the fire, it is 
possible that residents may have come in contact with contaminated water from 
firefighting activities as well as contaminated smoke. However, the response team sought 
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to minimize and prevent offsite migration of this water through the use of sand berms and 
vacuum pump trucks; therefore, it is unlikely that residents would have come in contact 
with contaminated runoff. In addition, the climate in January would have limited 
residents’ time outdoors, thus reducing exposure opportunities to contaminated smoke. 
Present and future exposure to contaminants from 54 Osgood Street is unlikely since 
contaminated debris and remaining hazardous materials were removed from the site 
following the 1994 fire. 
Reviewing the list of chemicals present at the time of the fire showed that the majority of 
chemicals onsite were most notable for their short-term (acute) effects. Most of the 
chemicals were some form of acid and would have caused a short-term burning sensation 
for individuals that came into contact with the smoke plume on the day of the fire. Two 
Methuen firefighters were transported to a local hospital on the day of the fire for 
possible chemical exposure after having been in the smoke (Weston 1994). Therefore, the 
chemicals in the smoke plume emanating from the fire may have presented an immediate 
hazard to local residents. However, the fire occurred in mid-January, and the high 
temperature for the day was 5º F. It is reasonable to assume that residents would have 
limited time outdoors on this day and likely remained indoors with the windows closed, 
thus limiting their exposure to the smoke plume. 
Copper is not classified as a human carcinogen by the EPA and typically is considered an 
essential nutrient important for good health (USEPA 2006b, ATSDR 2004). However, 
exposure to high levels of copper could result in adverse health effects including liver and 
kidney damage, anemia, immunotoxicity, and developmental toxicity (ATSDR 2004). 
Although the area sampled on the east bank of the Spicket River is located in a 
commercial/industrial area, it is possible that a child resident could visit this portion of 
the river and could have infrequent contact with the soil. To evaluate the potential for 
health effects from such exposure to copper, ATSDR Minimal Risk Levels (MRLs) were 
compared to exposure estimates for copper at the 54 Osgood site. The MRL is an 
estimate of daily exposure to a contaminant below which non-cancer, adverse health 
outcomes are unlikely to occur. Assuming a child resident inadvertently ingested 200 mg 
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of soil from the bank of the Spicket River containing the maximum concentration of 
copper detected in the area (1,590 ppm) for 2 days each week for 22 weeks (May through 
September, the warmer months of the year), a child resident would not be expected to 
experience increased non-cancer health effects.  
Site Status 
In response to a fire in 1994, immediate response actions were taken to minimize and 
prevent offsite migration of hazardous materials from the 54 Osgood Street property. 
Environmental sampling following the fire demonstrated that the Spicket River, as well 
as the surrounding properties, had not been adversely impacted by the fire (MDEP 
1995c). On January 9, 1995, the immediate response action was considered complete and 
no further action was deemed necessary (MDEP 1995c). 
V. Methods to Evaluate Health Concerns 
A. Analysis of Cancer Incidence 
As part of this investigation, the CAP reviewed cancer incidence data available from the 
MCR for brain cancer (all ages) and childhood cancer (all cancer types in ages 0 – 19) in 
Methuen. The 21-year period from 1982-2002 was evaluated and constituted the time 
period for which the most recent and complete cancer incidence data were available at the 
time of this report. [Coding for cancer types in this report follows the International 
Classification of Diseases for Oncology (ICD-O) system. See Appendix B for the 
incidence coding definitions used in this report.] The MCR is a division in the MDPH 
Bureau of Health Information, Statistics, Research, and Evaluation. It is a population-
based surveillance system that has been monitoring cancer incidence in the 
Commonwealth since 1982. All new diagnoses of invasive cancer, as well as certain in 
situ (localized) cancers, among Massachusetts residents are required by law to be 
reported to the MCR within 6 months of the date of diagnosis (M.G.L. c.111. s 111b). 
The MCR also gathers background information (e.g. gender, age, address at diagnosis) on 
each individual reported. This information is kept in a confidential database. Data are 
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collected daily and reviewed for accuracy and completeness on an annual basis. Due to 
the high volume of data collected and the 6-month period between diagnosis and required 
reporting, the most current registry data that are complete will inherently be a minimum 
of 2 years prior to the current date. 
To determine whether cancer incidence in a community is occurring at a higher or lower 
rate than expected, a statistic called a standardized incidence ratio (SIR) is calculated 
using data from the MCR. More specifically, the SIR is the number of observed cancer 
diagnoses in a town divided by the number of expected diagnoses multiplied by 100. The 
expected numbers are estimated using the age and gender distribution of the town and the 
state’s corresponding cancer rates. An SIR greater than 100 indicates that more cancer 
diagnoses occurred than expected; an SIR less than 100 means that fewer diagnoses 
occurred than expected. For example, an SIR of 150 is interpreted as 50 percent more 
diagnoses than expected; an SIR of 90 indicates 10 percent fewer diagnoses than 
expected. The SIR by itself is an estimate and the true SIR is unknown. Therefore, a 
related statistic, called the 95% confidence interval (CI), is used to interpret the SIR and 
determine if the SIR is statistically significant. 
Specifically, a 95% CI is the range of estimated SIR values that have a 95% probability 
of including the true SIR for the population. This range of numbers was calculated for 
each SIR to determine if the observed number of diagnoses was “significantly different” 
from the expected number or if the difference may be due solely to chance (Rothman and 
Boice 1982). If the 95% CI range does not include the value of 100, then the study 
population is considered significantly different from the comparison or “normal 
population.” “Significantly different” means there is less than a 5% chance that the 
observed difference (either increase or decrease) is the result of random fluctuation in the 
observed number of diagnoses. 
For example, if a confidence interval does not include 100 and the interval is above 100 
(e.g., 105-130), there is a statistically significant excess in the number of cancer 
diagnoses. Similarly, if the confidence interval does not include 100 and the interval is 
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below 100 (e.g., 45-96), then statistically this means that the number of cancer diagnoses 
is significantly lower than expected. If the confidence interval range includes 100, then 
the true SIR may be 100. In this case, it cannot be determined with certainty that the 
difference between the observed and expected number of diagnoses reflects a real cancer 
increase or decrease in cancer incidence or is the result of chance. 
In addition to the range of the SIR estimates contained in the confidence interval, the 
width of the confidence interval also reflects the stability of the SIR estimate. For 
example, a narrow confidence interval (e.g., 103-115) allows a fair level of certainty that 
the calculated SIR is close to the true SIR for the population. A wide interval (e.g., 85­
450) leaves considerable doubt about the true SIR, which could be much lower or higher 
than the calculated SIR. This would indicate an unstable statistic. Due to the instability of 
incidence rates based on a small number of diagnoses, statistical significance was not 
assessed when fewer than five diagnoses were observed. 
Because accurate age group and gender-specific population data are required to calculate 
SIRs, the census tract (CT) is the smallest geographic area for which cancer rates can be 
accurately calculated. Specifically, census tracts are small, relatively permanent 
geographic entities within counties (or the statistical equivalents of counties) defined by a 
committee of local data users following Census Bureau guidelines. Census tract 
boundaries normally follow visible features, but may follow governmental unit 
boundaries and other non-visible features in some instances. CTs usually contain between 
2,500 and 8,000 persons and are designed to be homogenous with respect to population 
characteristics (See Figure 2). Over time, a city or town changes population and the 
number of census tracts can change with the population. This occurred in the city of 
Methuen. In the 1980 U.S. Census, the city of Methuen had six different CTs, in the 1990 
U.S. Census it had 10 CTs, and in the 2000 U.S. Census it had 11 CTs (U.S. Census 
Bureau 1980, 1990 and 2000). All SIRs in this report were calculated using the 11 CTs 
that are currently in Methuen. 
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B. Review of Risk Factor Information 
Despite numerous scientific and medical investigations, the causes of brain cancer are 
still largely unknown. However, a few risk factors have been identified. For example, the 
most well-established risk factor is exposure to ionizing radiation (e.g., from radiation 
therapy to the head and neck) (ACS 2006a). In addition, rare diagnoses of brain cancer 
run in some families. Some types have also been associated with certain rare genetic 
disorders, such as neurofibromatosis types 1 and 2, von Hippel-Lindau disease, tuberous 
sclerosis, and Li-Fraumeni syndrome (ACS 2006a). Environmental factors, such as 
exposure to vinyl chloride, have shown inconsistent results when examined by 
researchers. Aspartame (a sugar substitute) and electromagnetic fields have also been 
suggested as risk factors for brain cancer, but the evidence does not support an 
association between these exposures and brain cancer (ACS 2006a). 
Brain and central nervous system (CNS) tumors can be either malignant (cancerous) or 
benign (non-cancerous). Primary brain tumors (i.e., brain cancer) comprise two main 
types: gliomas and malignant meningiomas.  Gliomas are a general classification of 
malignant tumors that include a variety of types, named for the cells from which they 
arise: astrocytomas, oligodendrogliomas, and ependymomas.  Meningiomas arise from 
the meninges, which are tissues that surround the outer part of the spinal cord and brain.  
Although meningiomas are not technically brain tumors, as they occur outside of the 
brain, they account for about 25% of all reported primary brain tumors and the majority 
of spinal cord tumors.  The majority of meningiomas (about 85%) are benign and can be 
cured by surgery. In addition to these main types, there are a number of rare brain 
tumors, including medulloblastomas, which develop from the neurons of the cerebellum 
and are most often seen in children.  Also, the brain is a site where both primary and 
secondary malignant tumors can arise; secondary brain tumors generally originate 
elsewhere in the body and then metastasize, or spread, to the brain (ACS 2006a). 
In adults, the most frequent types of brain tumors are astrocytic tumors (mainly 
astrocytomas and glioblastoma multiforme).  Incidence rates are higher in males than in 
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females for all types.  In general, the highest rates of brain and nervous system cancer 
tend to occur in whites. However, this varies somewhat by type; the incidence of 
gliomas is lower among black men and women than whites, but for meningiomas, the 
reverse is true (Preston-Martin and Mack 1996). 
Brain and spinal cord cancers account for over 20% of malignant tumors diagnosed 
among children aged 0-14 (ACS 2006b).  About half of all childhood brain tumors are 
astrocytomas and 25% are primitive neuroectodermal tumors (PNET), which spread 
along the spinal cord and the meninges (ACS 2006b).  After a peak in childhood 
(generally under 10 years of age), the risk of brain cancer increases with age from age 25 
to age 75. 
While there is little information on the causes of brain cancer, there is even less 
conclusive information on what is responsible for cancers that occur in children. Many of 
the lifestyle risk factors that are associated with some types of adult cancer (e.g., diet, 
smoking, and physical activity) are not relevant to childhood cancers. Some childhood 
cancers are the result of familial predisposition (cancer runs in families). Radiation 
exposures contribute to certain types of childhood cancers. However, the cause of most 
childhood cancers is not known (ACS 2006b). 
To better understand the pattern of brain and childhood cancers in Methuen, available 
case information from the MCR was evaluated for individuals diagnosed from 1982 to 
the present1. The information reviewed included date of diagnosis, age at diagnosis, 
histology (cancer cell type), and previous cancer diagnoses. However, information about 
personal risk factors that may also influence the development of brain or childhood 
cancer (e.g., family history or heredity) are not collected by the MCR, and therefore, 
could not be evaluated in this investigation. 
1 The cancer incidence data in this report are drawn from data entered on MCR computer files before 
September 6, 2007. The numbers presented in this report may differ slightly from those published in 
previous or future reports, reflecting late reported cases, address corrections, or other changes based on 
subsequent details from reporting facilities. 
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C. Geographic Distribution 
Address at the time of diagnosis was mapped for all childhood diagnoses of cancer and 
all brain cancer diagnoses in Methuen from 1982 to the present using ArcGIS software 
(ESRI 2005). Because the MCR is a continual surveillance system for cancer, it was 
possible to review case reports for more recent years (i.e., 2003-present) to qualitatively 
assess any possible spatial patterns of cancer diagnoses. However, because the data for 
the most recent years (i.e., 2003-present) are not complete, they cannot be used to 
calculate incidence rates. Due to community concerns related to the three sites (4 Gleason 
Street, 254 Broadway and 54 Osgood Street), particular attention was paid to the spatial 
pattern of brain cancer and childhood cancer in the census tract where these sites are 
located (CT 2523) as well as the two adjacent census tracts (CT 2524 & CT 2525.02) 
(See Figure 2). 
The MDPH is bound by law not to make public the names or any other information (e.g., 
place of residence) that could personally identify individuals with cancer whose 
diagnoses have been reported to the MCR (M.G.L. c.111. s. 24A). Therefore, for 
confidentiality reasons, it is not possible for the MDPH to release maps showing the 
locations of individuals diagnosed with cancer in public reports. However, a summary of 
the evaluation of geographic distribution with any notable findings is presented in this 
report. 
D. Hospital Discharge Database 
The Massachusetts Division of Health Care Finance and Policy (DHCFP) collects 
patient-level information on all patients who are discharged from hospitals in 
Massachusetts. The collection of data by the DHCFP is mandated by regulation 114.1 
CMR 17.00, Requirement for the Submission of Hospital Case Mix and Charge Data. 
Hospital discharge data are available through the MDPH Community Health Information 
Profile (MassCHIP) database. While the MCR collects address at diagnosis for each 
individual in its database, the hospital discharge database does not collect detailed 
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address information. Therefore, the CAP was able to examine aggregate data on asthma 
for the city of Methuen as a whole. 
Each hospitalization in Massachusetts is coded using the International Classification of 
Disease 9th Revision codes (ICD-9). The hospital discharge database was searched using 
the specific ICD-9 code for asthma, a respiratory condition that can be affected by 
environmental conditions (including air quality and exposure to respiratory irritants) and 
is of community interest. 
The data were examined to determine how many times individuals from Methuen were 
hospitalized with an asthma-related condition each year from 1989-2002. The statistic 
calculated and reported is the Standardized Hospitalization Ratio (SHR). The SHR is 
analogous to the SIR in its calculation and interpretation. However instead of counting 
individuals diagnosed with asthma, the SHR utilizes the number of hospitalizations for a 
city or town. 
There are some limitations to the data on asthma-related hospitalizations. First, unlike 
cancer data that are available at a smaller geographic level (i.e., census tract level), the 
data for hospitalizations are only provided by MassCHIP at the city/town level or at the 
zip code level. The city of Methuen has only one zip code that covers the entire city. This 
makes it impossible to determine if one area of the city is affected more than another area 
of the city. The SHR will only determine if Methuen is experiencing a higher or lower 
rate of hospitalizations from asthma-related conditions as compared to the state 
hospitalization rate. Another important limitation would be that these numbers are counts 
of hospitalizations for asthma, not the number of individuals who have asthma in a town 
or city. For example, if the database is examined for the number of asthma-related 
hospitalizations in Methuen during a specified time period, it would count one individual 
hospitalized ten times the same number of times as it would count ten individuals 
hospitalized once each. It is important to keep this information in mind when interpreting 
the hospital discharge data presented in this report. These data, however, should allow for 
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an evaluation of whether the population as a whole experienced respiratory impacts at 
greater rates during periods of possible contamination of the air.  
E. Evaluation of Neighborhood Survey 
The CAP reviewed the 11 surveys that were provided by a resident of the Gleason Street 
neighborhood with the original written request to the MDPH for a review of cancer 
incidence. Each survey identified an individual in Methuen who reportedly had been 
diagnosed with either brain cancer, an immune-related disease, or had experienced 
symptoms that he or she attributed to an environmental exposure. The survey collected 
information on symptoms, diagnoses, and residential history on a standardized form 
created by the residents of Methuen. 
A systematic surveillance system for the reporting of illnesses or conditions other than 
cancer did not exist in Massachusetts prior to 2004. Therefore, for the purposes of this 
report it is not possible to estimate the incidence or prevalence of diseases other than 
cancer. To evaluate the conditions mentioned in the surveys, the CAP researched the 
current medical literature for information relating to each condition as well as new data 
that have become available through an environmental public health tracking initiative 
funded by the United States Centers for Disease Control and Prevention (CDC). The CAP 
also looked for any specific environmental risk factors that could be associated with any 
of the diseases mentioned in the surveys. Also, the CAP assessed whether any 
commonalities appeared to exist among the diseases mentioned. 
VI. Results of Evaluation of Health Concerns 
A. Brain Cancer Incidence 
1. 1982-1988 
Table 6 summarizes the incidence of brain cancer for the city of Methuen during the 
seven-year time period of 1982-1988. Overall, the city experienced an increased 
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incidence of brain cancer. There were 25 diagnoses of brain cancer in Methuen when 
approximately 18 would have been expected to occur. However, this elevation in brain 
cancer incidence was not statistically significant (SIR=141, 95% CI=91-208). A separate 
evaluation by gender revealed that both males and females experienced an elevation in 
brain cancer incidence. However, neither males (12 observed versus 9.3 expected, 
SIR=129, 95% CI=66-225) nor females (13 observed versus 8.4 expected, SIR=154, 95% 
CI=82-263) had a statistically significant increase in the incidence of brain cancer. 
With the exception of one census tract (CT 2526.01), the number of observed diagnoses 
of brain cancer in Methuen’s census tracts was about as expected (i.e., within one of the 
number expected). In CT 2526.01, which is located on the eastern side of Methuen, there 
were seven brain cancer diagnoses observed when about two would have been expected 
(SIR=347, 95% CI=139-714). Both males and females residing in this CT experienced an 
elevated brain cancer incidence (males: 3 observed versus 1.1 expected, females: 4 
observed versus 0.9 expected). In the CTs that surround the sites of concern (CT 2523, 
CT 2524, and CT 2525.02), the number of individuals diagnosed with brain cancer during 
this time period was slightly below or approximately at the rate that would have been 
expected (CT 2523: 2 observed versus 2.7 expected; CT 2524: 2 observed versus 1.9 
expected; and, CT 2525.02: 2 observed versus 2.4 expected). 
a) Risk Factor Information 
The average age of individuals in Methuen diagnosed with brain cancer during this time 
period was 55 years with an age range of 1 to 85 years. In CT 2526.01, where a 
statistically significant elevation of brain cancer occurred, the average age at diagnosis 
was 62, with a range of 33 to 80 years of age. From 1982-1988, two of the 25 individuals 
(8%) diagnosed citywide were 19 years of age or younger at diagnosis when 
approximately two would have been expected. 
During this time period, the number of brain cancer diagnoses fluctuated from year to 
year, with anywhere between one and eight diagnoses occurring every year. There was, 
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however, no trend noted of either an increasing or decreasing number of diagnoses over 
time. 
Twenty-three of the 25 individuals (92%) were diagnosed with a glioma-type of brain 
cancer. This is the most common form of brain cancer. The two remaining diagnoses of 
brain cancer were both different subtypes of brain cancer. Among the 25 individuals 
diagnosed with brain cancer, one (4%) had a previous diagnosis of another cancer type. 
b) Geographic Distribution 
The geographic distribution of the 25 brain cancer diagnoses during 1982-1988 was 
consistent with the population distribution. A combined total of six brain cancer 
diagnoses occurred in CTs 2523, 2524, and 2525.02, the area of the three sites of 
concern, while seven would have been expected based on the statewide brain cancer 
experience. Two of the individuals lived within a ½-mile radius of the three sites at the 
time of their diagnosis while the remaining four did not.  
2. 1989-1995 
Table 7 summarizes the incidence of brain cancer in the city of Methuen during the 
seven-year time period of 1989-1995. Overall, the city experienced an increase in brain 
cancer incidence. There were 30 diagnoses in Methuen when approximately 20 would 
have been expected to occur. However, this elevation was not statistically significant 
(SIR=147, 95% CI= 99-210). During this time period, the elevation of brain cancer 
incidence occurred in both genders but neither males (16 observed versus 10.9 expected, 
SIR=146, 95% CI= 83-237) nor females (14 observed versus 9.5 expected, SIR=147, 
95% CI= 80-247) had a statistically significant increase. 
The observed number of diagnoses was near the expected number of diagnoses in six of 
the 11 CTs (i.e., within one of the number expected). In five of the 11 CTs (CTs 2521.01, 
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2521.02, 2522.01, 2523, and 2525.02), the number of observed diagnoses exceeded the 
number expected by two. In the CTs that include or surround the industrial sites of 
concern (CTs 2523, 2524, and 2525.02), the numbers of individuals diagnosed with brain 
cancer during this time period compared to what would have been expected were as 
follows: CT 2523: 5 observed versus 3.0 expected (SIR=169, 95% CI=54-340); CT 2524: 
1 observed versus 2.0 expected; and, CT 2525.02: 5 observed versus 2.6 expected 
(SIR=192, 95% CI=62-449). In CT 2525.02 four females were diagnosed when one 
would have been expected. Among males the occurrence of brain cancer occurred at 
about the expected rate (1 observed versus 1.4 expected). In CTs 2523 and 2525.02, the 
differences were not statistically significant. 
a) Risk Factor Information 
The average age of the individuals in Methuen diagnosed with brain cancer during this 
time period was 54 with an age range of 1 to 90 years. During this time period, four of 
the 30 (13%) individuals diagnosed with brain cancer were 19 years of age or younger 
when approximately two would have been expected. 
During this time period, the number of brain cancer diagnoses fluctuated from year to 
year, with between two and seven diagnoses occurring every year. There was, however, 
no trend noted of an increasing number of diagnoses over time. 
Twenty-six of the 30 (87%) individuals were diagnosed with a glioma. The four 
remaining individuals with brain cancer had three different brain cancer subtypes. None 
of the 30 individuals diagnosed with brain cancer had a previous diagnosis of any cancer 
type reported to the MCR.  Among the four children diagnosed with brain cancer during 
this time period, two different subtypes of brain cancer were diagnosed. 
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b) Geographic Distribution 
The geographic distribution of the 30 brain cancer diagnoses during 1989-1995 was 
consistent with the population distribution. While there was a combined total of 11 brain 
cancer diagnoses in CTs 2523, 2524, and 2525.02, the area of the three sites of concern, 
four of the diagnoses lived within a ½-mile radius of the three sites at the time of their 
diagnosis while the remaining seven did not. Approximately eight diagnoses would have 
been expected in these three CTs. 
3. 1996-2002 
Table 8 shows the overall incidence of brain cancer in the city of Methuen during the 
seven-year time period of 1996-2002. Overall, Methuen experienced an increased 
incidence of brain cancer. There were 29 diagnoses in Methuen when approximately 23 
would have been expected to occur. However, this elevation was not statistically 
significant (SIR=128, 95% CI= 85-183). The elevation in brain cancer incidence occurred 
in both genders with neither males (16 observed versus 12.0 expected, SIR=133, 95% 
CI= 76-215) nor females (13 observed versus 10.7 expected, SIR=122, 95% CI= 62-208) 
having a statistically significant increase in the incidence of brain cancer. 
With the exception of two CTs (2523 and 2526.01), the number of observed diagnoses of 
brain cancer in Methuen’s CTs occurred about as expected (i.e., within one of the number 
expected.) The two CTs each had six diagnoses of brain cancer when approximately three 
were expected in each CT. Neither SIR was statistically significantly elevated. When 
brain cancer incidence was examined by gender, males in CT 2523 had a statistically 
significant elevation in brain cancer incidence with five males diagnosed when 
approximately two would have been expected (SIR=312, 95% CI= 101-728). In the CTs 
that surround the three sites of concern (CTs 2523, 2524, and 2525.02), the number of 
individuals diagnosed with brain cancer during this time period versus the number 
expected was as follows: CT 2523: 6 observed versus 3.2 expected (SIR=186, 95% 
CI=68-406); CT 2524: 0 observed versus 1.7 expected; and, CT 2525.02: 4 observed 
versus 2.9 expected. 
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a) Risk Factor Information 
The average age of the individuals in Methuen diagnosed with brain cancer during 1996­
2002 was 58 with an age range under 1 year of age to 92 years of age. In CT 2523, which 
had the statistically significant elevation of brain cancer diagnoses among males (5 
observed versus 1.6 expected), the average age of the individuals at diagnosis was 46, 
with a range of 7 to 92 years of age. Three of the 29 (10%) individuals diagnosed 
citywide with brain cancer were 19 years of age or younger when approximately two 
would have been expected. These three children were diagnosed with two different 
subtypes of brain cancer. 
During this time period, the number of brain cancer diagnoses fluctuated from year to 
year. There was, however, no trend noted of either an increasing or decreasing number of 
diagnoses over time. 
Twenty-seven of the 29 (93%) individuals were diagnosed with a glioma. The two 
remaining individuals with brain cancer had two different subtypes of brain cancer. Three 
of the 29 individuals had a previous diagnosis of another cancer type. 
b) Geographic Distribution 
The geographic distribution of the 29 brain cancer diagnoses during 1996-2002 was 
consistent with the population distribution. There was a combined total of 10 brain cancer 
diagnoses in CTs 2523, 2524, and 2525.02, the area of the three sites of concern, when 
approximately eight diagnoses would have been expected in these three CTs. The 10 
brain cancer diagnoses were not distributed among all three of the CTs. Four of the 10 
individuals lived within a ½-mile radius of the three sites at the time of their diagnosis. In 
CT 2523 six individuals were diagnosed with brain cancer when approximately three 
would have been expected; two of the three children diagnosed with brain cancer in this 
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CT lived in close proximity to one another.  The remaining four individuals resided in CT 
2525.02 where approximately three diagnoses would have been expected and no 
individuals resided in CT 2524 when approximately two would have been expected.   
4. 2003-present 
There have been an additional 12 diagnoses of brain cancer among residents of Methuen 
reported to the MCR since 2002. The age range for these diagnoses was from 4 to 82 
years of age, with an average age of 51. When the spatial pattern of these current 
diagnoses was examined, there was no apparent clustering of the diagnoses within 
Methuen. Two of these diagnoses were among individuals under the age of 19 and one of 
the children resided in CT 2523. The other child was diagnosed while living in CT 
2521.01 
B. Childhood Cancer Incidence 
1. 1982-1988 
Table 9 summarizes the incidence of childhood cancer in the city of Methuen during the 
7-year time period of 1982-1988. Children living in Methuen during this time period 
experienced an incidence of cancer that was about what would be expected based on the 
statewide childhood cancer rate. There were 11 diagnoses of childhood cancers in 
Methuen when 11.4 would have been expected to occur (SIR=96, 95% CI= 48-172). 
Neither gender had an increased incidence of childhood cancers (males: 6 observed 
versus 6.2 expected; females: 5 observed versus 5.3 expected). For each CT, the number 
of observed diagnoses was about what was expected. In the CTs that surround the three 
sites of concern (CTs 2523, 2524, and 2525.02), the number of children diagnosed with 
cancer during this time period was lower than what would have been expected (CT 2523: 
0 observed versus 1.6 expected; CT 2524: 1 observed versus 1.9 expected; and, CT 
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2525.02: 0 observed versus 1.2 expected). Overall one child was diagnosed with cancer 
when approximately five would have been expected. 
a) Risk Factor Information 
Among the 11 children diagnosed with cancer during this time period, there were eight 
different types of cancer diagnosed (neuroblastoma, brain, Hodgkin’s disease, leukemia, 
ovarian, Ewing’s sarcoma and a germ cell tumor). The 11 diagnoses were spread across 
the 7-year time period, with each year having at least one diagnosis of a cancer in an 
individual aged 19 or under. The ages of the 11 children at diagnosis also varied from 
under 1 year of age to 18 years of age. The age at diagnosis for each individual was 
consistent with what would be expected for the type of cancer diagnosed. 
b) Geographic Distribution 
The geographic distribution of the cancer diagnoses was generally consistent with the 
population distribution. In the three CTs of concern (CT 2523, 2524, and 2525.02), there 
was one diagnosis of cancer when approximately five would have been expected. At the 
time of diagnosis, this child lived more than a ½-mile away from the three sites of 
concern in central Methuen. 
2. 1989-1995 
Table 10 summarizes the incidence of childhood cancer in the city of Methuen during the 
seven-year time period of 1989-1995. Children living in the city during this period 
experienced an incidence of cancer that was about what would be expected. There were 
13 diagnoses of childhood cancers in Methuen when approximately 12 diagnoses would 
have been expected to occur (SIR=109, 95% CI= 58-186). The incidence of childhood 
cancers was about as expected for both genders (males: 8 observed versus 6.7 expected, 
females: 5 observed versus 5.2 expected). For each CT, the number of observed 
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diagnoses was about what was expected. In the CTs that surround the three sites of 
concern (CT 2523, 2524, and 2525.02), the number of children diagnosed with cancer 
during this time period was approximately as expected (CT 2523: 2 observed versus 1.5 
expected; CT 2524: 2 observed versus 2.3 expected; and, CT 2525.02: 3 observed versus 
1.1 expected). 
a) Risk Factor Information 
Among the 13 children diagnosed with cancer during this time period, there were eight 
different types of cancer diagnosed (liver, colorectal, brain, Hodgkin’s disease, non-
Hodgkin’s lymphoma, leukemia, germ cell and neuroepithelial). The 13 diagnoses were 
spread across the 7-year time period, with each year in the time period having at least one 
diagnosis of cancer in an individual 19 years of age or under. The ages at diagnosis for 
the 13 children ranged from 1 year to 18 years of age. The ages of diagnosis were 
consistent for the types of cancer diagnosed. 
b) Geographic Information 
The geographic distribution of residence at time of cancer diagnosis was generally 
consistent with the population distribution. In the three CTs of concern (CT 2523, 2524, 
and 2525.02), there were seven diagnoses of cancer and one of the children lived within a 
½-mile of the three sites of concern. Approximately five diagnoses were expected in the 
three CTs. There were no brain cancer diagnoses among children residing within a ½­
mile of the three sites. 
3. 1996-2002 
Table 11 summarizes the incidence of childhood cancer in the city of Methuen during the 
7-year time period of 1996-2002. Children experienced an incidence of cancer that was 
about what would be expected. There were 12 diagnoses of childhood cancers in 
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Methuen when approximately 13 diagnoses would have been expected to occur (SIR=90, 
95% CI= 46-157). Both genders experienced an incidence of childhood cancers that was 
about as expected (males: 8 observed versus 7.2 expected; females: 4 observed versus 6.2 
expected). In two of the three CTs that surround the three sites of concern (CTs 2524 and 
2525.02), the number of children diagnosed with cancer during this time period was close 
to what would have been expected (CT 2524: 0 observed versus 1.8 expected and CT 
2525.02: 1 observed versus 1.2 expected). CT 2523 had five observed diagnoses of 
cancer when approximately two would have been expected (SIR=309, 95% CI= 100­
723); this difference represents a borderline statistically significant elevation in the 
number of children diagnosed with childhood cancer. 
a) Risk Factor Information 
Among the 12 children diagnosed with cancer during this time period, there were eight 
different types of cancer diagnosed (melanoma, ovarian, kidney, brain, thyroid, 
Hodgkin’s disease, non-Hodgkin’s lymphoma, and neuroblastoma). The 12 diagnoses 
were spread across the 7-year time period with 6 of the 7 years having at least one 
diagnosis of cancer in a child; in 1998 were there no diagnoses of childhood cancer. 
b) Geographic Distribution 
In the three CTs of concern (CT 2523, 2524, and 2525.02), there were six diagnoses of 
cancer and approximately five would have been expected. Four of the children lived 
within a ½-mile of the three sites of concern and three had a diagnosis of brain cancer. 
Their dates of diagnosis were spread out across the time period and two different 
histological subtypes of brain cancer were identified. 
4. 2003-present 
Since 2002, an additional 13 cancer diagnoses among 12 children have been reported to 
the MCR. These diagnoses varied in type (Hodgkin’s disease, Non-Hodgkin’s 
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Lymphoma, leukemia, retinoblastoma, neuroblastoma, and brain, skin, bone, and kidney 
cancers) and were not concentrated in any area of Methuen. There were six diagnoses 
among females and seven diagnoses among males from 2003 to the present. One of the 
13 diagnoses was brain cancer; this individual’s residence at the time of diagnosis was 
within ½ of a mile of the three sites of concern. 
C. Asthma Incidence 
Table 12 summarizes the number of hospitalizations for asthma-related conditions for the 
city of Methuen for each year from 1989 to 2002. Overall, the number of asthma-related 
hospitalizations was either around or below the expected value. For several of the years 
(1994-1996 and 1999-2002) the number of hospitalizations was statistically significantly 
lower than expected. When examined by gender the number of asthma-related 
hospitalizations was about as expected or lower each year for both males and females. 
There were several years (1995 and between 1999 and 2002) when asthma-related 
hospitalizations were statistically significantly lower than expected among both genders. 
Also, females experienced other years of statistically significantly lower number of 
asthma-related hospitalizations (1990, 1994 and 1996). 
D. Survey Evaluation and Risk Factor Information 
Included in the original request to MDPH for an investigation were 11 surveys completed 
by individuals who lived around the three sites and who reported having a variety of 
different diseases. The neighborhood survey was initiated and conducted by a concerned 
resident. All of the information was reportedly provided by the individual or a relative, 
when an individual was not available to complete the survey. The surveys identified a 
wide variety of self-reported illnesses including brain cancer, Multiple Sclerosis (MS), 
Myasthenia Gravis, asthma, and possible immune-mediated hearing loss. 
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CAP reviewed the information provided on each survey. The scientific literature was 
searched for relevant information about environmental exposures that could potentially 
be related to the reported disease. New data from MDPH’s environmental public health 
tracking initiative was also reviewed as appropriate. The following discussion of each 
disease mentioned in the surveys explores the basic mechanisms of the disease, the 
prevalence (and/or incidence) and any known (or suspected) risk factors for each disease. 
It was not possible for the CAP to determine the cause of any one person’s illness. 
Pertinent information such as an individual’s medical history, family history of disease, 
and lifestyle information may be important in the development of an individual’s disease. 
One or several factors acting over time can be related to the development of a disease. 
The individuals who completed the surveys ranged in age from 8 to 62 years old. All of 
the individuals were living in Methuen at the time they completed the survey, but most 
had not been at their reported addresses for their entire lives. The number of years for 
which each individual had been living at their current address ranged from 6 to 33 years. 
Individuals provided a previous address to the one where they were living at the time of 
the survey. 
1. Brain Cancer 
Two of the surveys were for individuals in Methuen who had been diagnosed with brain 
cancer. As discussed previously in this report, there is little scientific information on the 
causes of brain cancer. One reason for the lack of understanding of the risk factors for 
brain cancer is the unusually diverse array of histologic (cell) types. Risk factors are 
discussed below. 
Exposure to ionizing radiation is the only established environmental risk factor. 
Individuals can be exposed to high doses of ionizing radiation when they are treated for 
various types of cancer. Historically, ionizing radiation was also used to treat an 
assortment of non-cancerous conditions [i.e. tinea capitus (ringworm of the scalp)] 
(Savitz and Trichopoulos 2002). While the practice of using ionizing radiation as a 
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treatment for benign, non-cancerous conditions has declined to a great extent, it is still in 
use by doctors today for a limited number of medical conditions (Abson 2000). As 
mentioned previously, information collected by the MCR does not provide details about 
past medical treatments of individuals diagnosed with cancer. Appendix C provides 
further discussion of risk factor information on brain cancers. 
The incidence of brain cancer in the general population has been described as having two 
peaks, one in early childhood prior to the age of 10 and then another peak in older 
individuals around the age of 70 (Savitz and Trichopoulos 2002). As with many types of 
cancer, the incidence of brain cancer increases with age. The age distribution of those 
Methuen individuals diagnosed with brain cancer is consistent with national and state 
patterns. 
2. Immune-Related Diseases 
Six of the remaining nine individuals listed a disease on their survey that involves the 
immune system. The immune system utilizes various mechanisms to protect the body 
against disease. Generally, the body is protected either by a passive defense such as a 
physical barrier, like the skin, or an active defense by various cells of the immune system. 
When the active immune system does not work properly it can cause one of the following 
conditions: 
− an autoimmune disease (e.g., an immune response against the body) 
− an allergic disease (e.g., a normal immune response to a foreign antigen that 
damages normal tissue) 
− an immunodeficiency disease (e.g., the body cannot generate an appropriate 
immune response against invading microorganisms) 
Each of the following four diseases fit into one of these three categories of immune- 
related diseases. 
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a) Multiple Sclerosis 
Three of the individuals who completed a survey reported a diagnosis of Multiple 
Sclerosis (MS). MS is an autoimmune disease that damages or destroys patches of myelin 
(the protective coating on nerve cells) and the underlying nerve fibers in the eyes, brain, 
and spinal cord. This damage affects the ability of nerves to conduct electrical impulses 
to and from the brain. Individuals with MS generally develop problems with their muscle 
control. 
MS is a major cause of nervous system disability among young people (i.e., individuals 
under the age of 45) in the United States (Lutton et al. 2004). MS is most frequently 
diagnosed in adults between the ages of 20 and 40, with prevalence highest in the 40 to 
59 year age range (Nielsen et al. 2005; Noonan et al. 2002). Women are generally 
diagnosed with MS at a rate of roughly two to one compared to males. The prevalence 
(number of people currently living with the disease) of MS is estimated to be somewhere 
between 60 and 140 diagnoses per 100,000 individuals (NMSS 2002). In an MDPH study 
to estimate the prevalence of MS in southeastern Massachusetts for the period 1998 – 
2003, a prevalence rate of 146 per 100,000 population was estimated after reviewing the 
medical records of neurologists serving the study population.  This estimate is within the 
range observed in other studies conducted in the northern latitudes (north of the 37th 
parallel); some studies have shown a higher prevalence of MS in northern latitudes 
compared to southern latitudes.  However, the prevalence of MS in others parts of the 
state may be higher or lower than this estimate. In the 2000 U.S. Census the city of 
Methuen had approximately 43,789 residents, meaning that roughly 60 individuals in 
Methuen would be expected to have MS at any one time. 
The causes of MS are still unknown, but many studies have suggested that genetics and 
environmental exposures may play a role in the development of MS. That is, MS is 
thought to be a disease resulting from the complex interplay of genes and environmental 
factors. Hundreds of epidemiological studies have been conducted of MS and some have 
reported associations between MS and exposure to viral agents, organic solvents, low 
temperatures, trauma, and various other factors. Several viruses thought to raise an 
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individual’s risk of developing MS are the Epstein-Barr virus (EBV) and Human Herpes 
virus [HHV (specifically HHV-6 and HHV-8)] (Cook 2004; Lutton et al. 2004). The 
National MS Society (NMSS) characterizes MS as a disease that is not directly inherited, 
but one for which those inflicted carry a genetic predisposition for the disease. In 
addition, the NMSS believes that MS may be triggered by something in the environment, 
such as an infectious viral or bacterial agent. It may be that no single agent will ever be 
shown to exert a cause-and-effect relationship, but rather that people with genetically 
predisposed immune systems may react to certain bacteria, viruses, or other 
environmental agents in a way that results in the expression of MS.  
b) Myasthenia Gravis 
One of the individuals who completed a survey reported a diagnosis of Myasthenia 
Gravis. Myasthenia Gravis is a disease in which the body’s own antibodies bind to 
acetylcholine receptors in muscle cells, thereby impairing muscle contraction. Receptors 
are structures on the surface of cells that react with specific stimuli. Acetylcholine is a 
neurotransmitter (stimulus) that conveys impulses between the ends of nerve cells and 
muscle cells. An individual diagnosed with Myasthenia Gravis has fewer acetylcholine 
receptors available to receive the message that a nerve is trying to transmit; this leads to 
muscle fatigue and weakness due to a lack of proper stimulation by the nerves. The 
mechanism of this disease is one of the most thoroughly understood of the autoimmune 
diseases. It has served as a model for understanding the mechanisms of other autoimmune 
diseases (Drachman 1994). 
The first symptoms of Myasthenia Gravis can appear at any age; however, they usually 
appear at an early age in women while, among males, the disease more commonly occurs 
at older ages. The incidence in women peaks in their 20’s and 30’s while in males in their 
50’s and 60’s (Thanvi and Lo 2004). The prevalence of Myasthenia Gravis is estimated 
to be somewhere between 10 and 20 diagnoses per 100,000 individuals in the United 
States (Phillips 2004). 
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Similar to other autoimmune diseases, the cause of Myasthenia Gravis is thought to be a 
complex interaction between genetics and the environment (Drachman 1994). The 
thymus (a gland located in the chest behind the breastbone) is believed to play a role in 
Myasthenia Gravis. The removal of the thymus, a procedure called a thymectomy, 
relieves the symptoms for some individuals with Myasthenia Gravis (Budde et al. 2001). 
Other than the possible role that the thymus may play in Myasthenia Gravis, no clear 
picture exists as to the origin of the disease. A search of the current literature did not 
identify any chemical contaminants in the soil, air, or water as likely risk factors for the 
development of Myasthenia Gravis. 
c) Asthma 
One of the individuals surveyed in Methuen reported a diagnosis of asthma. Asthma is an 
immunological disease, but it is not an autoimmune disease like the other diseases 
mentioned previously. Asthma is a reversible obstructive lung disease caused by 
increased reaction of the airways to various stimuli. When an individual suffers from 
asthma, the muscles of the airways constrict causing an interruption in normal breathing. 
Male children are more likely to be diagnosed with asthma than female children. This 
gender inequality changes once individuals reach adulthood when women become more 
likely than men to develop asthma (ALA 2005). Asthma that occurs in childhood will 
sometimes resolve itself before adulthood. Currently about 7% of the entire U.S. 
population suffers from asthma. Children are more likely to be diagnosed with asthma 
than adults, however, with approximately 12.5% of children in the US having been 
diagnosed with asthma (Dey and Bloom 2005). In the last few decades the prevalence of 
asthma has been increasing, especially among children. The reason for this increase has 
yet to be explained. Data available from the MDPH’s environmental public health 
tracking program indicate that the current rate of pediatric asthma is 10% for the state as 
a whole. The city of Methuen’s pediatric asthma rate in the 2004-2005 school year was 
8.2% (95% CI 7.5% - 9.0%) (MDPH 2006). 
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Although there is medical agreement on agents that can trigger asthma, such as cold air 
and allergens like animal dander, current information in the medical literature does not 
provide firm conclusions about the causes or risk factors for the onset of asthma. Many 
researchers have sought to identify specific environmental exposures associated with the 
development of asthma. In a report by the Institute of Medicine for the EPA, on both 
exposures related to asthma onset and the worsening of already established asthma, 
exposure to house dust mites was reported to cause asthma onset while exposure to 
environmental tobacco smoke among preschool age children was reported to be 
associated with asthma onset (meaning the weight of the evidence for causation was less 
for environmental tobacco smoke than for house dust mites) (Redd 2002). It is well-
documented that outdoor exposures to ozone and particulate matter can exacerbate 
asthma. However, whether outdoor pollution is associated with asthma onset is not 
known. Data available from the MDPH’s environmental public health tracking program 
suggests that indoor exposure to moisture and/or mold may be associated with increased 
rates of pediatric asthma. 
d) Autoimmune Inner Ear Disease 
One of the individuals who completed a survey reported bilateral hearing loss and was 
told by their physician that it was an autoimmune-related condition. A medical condition 
called Autoimmune Inner Ear Disease (AIED) can cause sudden bilateral hearing loss 
and tinnitus (Werneck et al. 2003). Currently about one in 10 individuals in the United 
States suffer from some form of hearing loss and about one-third of individuals over 65 
have significant hearing loss (Lalwani and Snow 2005). However, AIED is rare. Less 
than 1% of hearing loss incidence in the population can be accounted for by AIED 
(Werneck et al. 2003). 
The condition of autoimmune hearing loss was first described in 1979 (McCabe 1979). 
Multiple potential mechanisms have been identified that can result in AIED, but there is 
no accepted mechanism of disease (Ruckenstein 2004). In a search of current medical 
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literature, no articles were found that either examined or hypothesized environmental 
factors as being involved in the development of AIED. 
3. Other illnesses 
In the remaining three surveys, the individuals did not list any specific medical 
conditions. Each survey listed numerous symptoms that could be associated with several 
different diseases. Due to a lack of information, it is not possible to discuss what may be 
causing these symptoms or how the symptoms may be related to the environment. 
VII. Discussion 
At the request of concerned residents, the Community Assessment Program (CAP) at the 
Massachusetts Department of Public Health (MDPH), Bureau of Environmental Health 
(BEH), conducted an evaluation of three state-regulated former industrial sites and cancer 
incidence for the city of Methuen. This evaluation was initiated because of community 
concerns about a suspected increase in the overall incidence of brain cancer and 
childhood cancer (individuals aged 19 and under at diagnosis) among individuals living 
near of three former industrial sites at 4 Gleason Street, 254 Broadway, and 54 Osgood 
Street in central Methuen. Two of the sites, 4 Gleason Street and 254 Broadway, were 
industrial sites in central Methuen dating back to the mid-1800s. The third site, 54 
Osgood Street, was the scene of a fire that destroyed a building housing hazardous 
material.  
Environmental contamination associated with the three former industrial sites in central 
Methuen of concern to some residents was evaluated for the potential of exposure to 
nearby residents and subsequent health risks. The evaluation found the opportunities for 
exposure to contaminants to be limited. The hazardous materials release at 54 Osgood 
Street was a single event in January 1994 associated with a fire that destroyed a building 
on the property. The release from the fire was found not to have impacted surrounding 
properties and exposure opportunities for residents were limited. Compared to the 1-day 
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event that occurred at 54 Osgood Street, the contaminants at 4 Gleason Street and 254 
Broadway were potentially present for a longer period of time due to historical industrial 
activities at both locations. The groundwater in this area was not and is not used as a 
source of drinking water. No increased risks of cancer or other adverse effects were 
predicted assuming a nearby resident to the two sites regularly came into contact with the 
maximum detected concentrations of soil, surface water or sediment contaminants at the 
sites. The three sites have been remediated, are currently vacant, and access to them is 
limited. 
In response to community concerns the CAP examined in this report the incidence of 
certain cancers for the city of Methuen. This report is descriptive in nature and therefore 
has certain inherent limitations. The results of a descriptive investigation cannot be used 
to establish a causal link between a particular risk factor (either environmental or non-
environmental) and a disease outcome (Adami and Trichopoulus 2002). Neither can it 
determine what may have caused cancer or another disease in any one individual. 
However, the results can be useful in identifying areas where further public health 
investigations or interventions may be warranted. Despite the limitations of descriptive 
studies, these types of studies can help to identify patterns of risk factors that may exist, 
such as behaviors or opportunities for environmental exposures, in a geographic context. 
Understanding that cancer is not one disease, but a group of diseases is very important. 
Research has shown that there are more than 100 different types of cancer, each with 
different causative (or risk) factors. In addition, cancers of a certain tissue type in one 
organ may have a number of causes. Cancer may also be caused by several factors acting 
over time. Tobacco use has been linked to lung, bladder, oral and pancreatic cancers. 
Other factors related to certain cancers may include lack of crude fiber in the diet, high 
fat consumption, alcohol abuse, and reproductive history. Family history (or genetics) is 
an important risk factor for several cancers. In addition, some occupational exposures, 
such as jobs involving contact with asbestos, have been shown to increase the risk of 
developing cancer. Environmental contaminants have also been associated with certain 
types of cancers (Bang 1996; Frumkin 1995). 
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According to statistics from the American Cancer Society, cancer is the second leading 
cause of death in Massachusetts and the United States. Not only will one out of three 
females and one out of two males develop cancer in their lifetime, but cancer will affect 
three out of every four families. For this reason, cancers often appear to occur in 
“clusters,” and it is understandable that someone may perceive that there are an unusually 
high number of cancer diagnoses in their surrounding neighborhoods or towns. Upon 
closer examination, many of these “clusters” are not unusual increases, as first thought, 
but are related to such factors as local population density, variations in reporting or 
chance fluctuations in occurrence. In other instances, the “cluster” in question includes a 
high concentration of individuals who possess related behaviors or risk factors for cancer. 
Some, however, are unusual; that is, they represent a true excess of cancer in a 
workplace, a community, or among a subgroup of people. A suspected cancer cluster is 
more likely to be a true cluster if it involves a large number of diagnoses of one type of 
cancer diagnosed in a relatively short time period rather than several different types 
diagnosed over a long period of time (i.e., 20 years), a rare type of cancer rather than 
common types, and a large number of diagnoses diagnosed among individuals in age 
groups not usually affected by that cancer. These types of clusters may warrant further 
public health investigation. 
In general, while the city of Methuen experienced an elevated incidence in brain cancer 
during each of three time periods examined, the elevation was not statistically significant 
citywide in any of the time periods. Given that the elevations were not statistically 
significant, the role of chance is still a possible explanation for the higher incidence of 
brain cancer in Methuen. When the overall age and gender patterns of brain cancer 
incidence were examined in more detail, no unusual trends emerged. The brain cancer 
subtypes (histology distribution) for the diagnoses in each time period were also 
consistent with both state and national trends. There was no apparent temporal clustering 
of diagnoses and the number of diagnoses fluctuated from year to year, ranging from one 
to eight diagnoses in any year. Furthermore, no statistically significant elevations in brain 
cancer or childhood cancer were seen that persisted over the time periods evaluated. 
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At the census tract level, two census tracts experienced a statistically significant elevation 
in brain cancer during two different time periods. In the earliest time period, 1982-1998, 
in CT 2526.01 in eastern Methuen, seven diagnoses were reported when two were 
expected. In the next time period, this census tract had slightly fewer diagnoses than 
expected. In the last time period, more diagnoses occurred than expected but the 
difference was not statistically significant. CT 2523, in central Methuen, where the three 
areas of environmental concern are located, had a statistically significant elevation among 
males during the 1996-2002 time period. Brain cancer occurred about as expected in 
males during 1982-1988 and was slightly elevated in males during 1989-1995. 
During each time period evaluated, the incidence of childhood cancers in Methuen was 
about what would have been expected based upon the rates of all cancers among children 
in the entire state. Between 1982 and 1996, no children living within a ½-mile of 4 
Gleason Street or 254 Broadway were diagnosed with brain cancer. Between 1996 and 
2002, there were three diagnoses of brain cancer among children living within a ½-mile 
of the two sites. There were no other diagnoses of brain cancer among children in the city 
of Methuen during this time period; approximately two children would have been 
expected to be diagnosed with brain cancer in Methuen as a whole. There was a fourth 
child diagnosed with brain cancer within a ½-mile of the two sites during the 2003­
present time frame. 
The number of asthma-related hospitalizations in the city of Methuen was consistently 
either at or below what would have been expected. If excessive pollutants were present in 
the air, especially in 1994, the year of the 54 Osgood Street fire, then they would be 
expected to exacerbate asthma in Methuen residents and send them to the hospital on a 
more frequent basis than other residents of Massachusetts. This would raise the number 
of hospitalizations for asthma-related conditions and the Standardized Hospitalization 
Ratio for asthma hospitalizations would be elevated. However, this was not seen with the 
data presented in this report. 
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Statistics on autoimmune disease incidence statewide and for most cites and towns 
throughout the Commonwealth were not available. Similar to other state health 
departments throughout the country, Massachusetts does not have a statewide registry to 
track diagnoses of autoimmune diseases such as MS and Myasthenia Gravis. However, 
through the new environmental public health tracking initiative, Massachusetts is 
generating surveillance estimates specific to the Commonwealth. Based upon MS 
prevalence estimates, Methuen would be expected to have approximately 60 individuals 
with MS. 
No specific pattern of brain or childhood cancer emerged that was statistically significant 
and persisted over time to suggest that a common environmental factor is likely related to 
the incidence of these cancers. The spatial pattern of the diagnoses did not suggest a 
common environmental factor related to the diagnoses of brain or childhood cancer. In 
addition, no significant health risks were predicted upon review of the available 
environmental data for the three sites evaluated in this report. 
VIII. Child Health Considerations 
ATSDR and MDPH recognize that the unique vulnerabilities of infants and children 
demand special emphasis in communities faced with contamination of their environment. 
Children are at a greater risk than adults from certain kinds of exposure to hazardous 
substances emitted from waste sites. They are more likely to be exposed because they 
play outdoors and because they often bring food into contaminated areas. Because of 
their smaller stature, they might breathe dust, soil, and heavy vapors close to the ground. 
Children are also smaller, resulting in higher doses of contaminant exposure per body 
weight. The developing body systems of children can sustain permanent damage if 
certain toxic exposures occur during critical growth stages. Most importantly, children 
depend completely on adults for risk identification and management decisions, housing 
decisions, and access to medical care. 
The incidence and patterns of cancer among children in Methuen is discussed in Section 
VI (“Results of Evaluation of Health Concerns”) of this report. As discussed before, past 
exposure to onsite contamination at 4 Gleason Street and 254 Broadway could have been 
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possible for children prior to remediation of the sites in 2005 and 2006. However, it is 
unlikely that anyone would have had sufficient contact with soil and sediment at the two 
sites for a sufficient frequency and duration of time to result in health effects. Present and 
future exposures are not of concern because contaminated soil, sediment, or surface water 
have been removed. No other exposures were identified that would indicate that children 
are more likely than adults to be impacted by 4 Gleason Street and 254 Broadway.  As 
with adults, the likelihood of health impacts to children from the fire at 54 Osgood Street 
was determined to be unlikely, based on an evaluation of fire conditions and 
consideration of the possibility of exposure of nearby residents. 
IX. Limitations 
Although data for air and runoff water at 54 Osgood Street were limited to those 
measurements obtained during and after the January 15, 1994 fire, the limited air data 
indicate that health impacts from the fire were unlikely. Soil data were also limited 
geographically to only those properties in close proximity to the 54 Osgood Street 
property. However, these data indicate that soil at these locations is not expected to pose 
a health threat to residents. In addition, because the highest concentrations of 
contaminants are typically closer to the source, residential properties located at increasing 
distances from the source would likely have even lower concentrations (if any) that 
would be unlikely to pose a threat to nearby residents. 
This health consultation is an investigation that analyzes descriptive health outcome data 
for cancer to determine whether the pattern or occurrence of selected cancers is unusual. 
Information from descriptive analyses, which may suggest that a common etiology (or 
cause) is possible, can serve to identify areas where further analyses are needed. Inherent 
limitations in this type of analysis and the available data make it difficult at best to 
determine causal relationships or synergistic roles that may have played a part in the 
development of individual cancers in these communities. Cancers in general have a 
variety of risk factors known or suggested to be related to the etiology (cause) of the 
diseases. Behavioral factors such as tobacco use, diet, and alcohol consumption are 
considered the most important risk factors for a number of cancers. Other factors 
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associated with cancer are socioeconomic status, reproductive factors, exposure to 
infectious agents (i.e., viruses) and heredity/genetics. It is beyond the scope of this report 
to determine the causal relationship of these factors and the development of cancer or 
other health outcomes in the CTs of Methuen. 
X. Conclusions 
•	 Environmental contamination associated with the three sites in central Methuen of 
concern to some residents was evaluated for the potential of exposure to nearby 
residents and subsequent health risks. The evaluation found the opportunities for 
exposure to contaminants to be limited. The groundwater in this area was not and is 
not used by anyone as a source of drinking water. No increased risks of cancer or 
other adverse health effects were predicted assuming a nearby resident regularly 
came into contact with the maximum detected concentrations of contaminants in the 
soil, sediment, or surface water at the three sites. The three sites were remediated, 
are currently vacant, and access to them is limited. 
•	 At the citywide level, the incidence of brain cancer in Methuen was elevated for 
three time periods (1982-1988, 1989-1995 and 1996-2002). None of the elevations 
were statistically significant, meaning that chance or random fluctuation cannot be 
ruled out as a reason for the increased incidence. 
•	 At the census tract level, no single Methuen CT had a consistently elevated 
 
incidence of brain cancer over the three time periods that was statistically 
 
significant. 
 
•	 There were two CTs where the incidence of brain cancer was statistically 
significantly elevated for one of the three time periods. In CT 2526.01, during 
1982-1988, an overall elevation of brain cancer was found with seven diagnoses 
observed when two would be expected. In the two subsequent time periods in CT 
2526.01, brain cancer incidence was lower than expected during 1989-1995 and 
higher than expected during 1996-2002, although not statistically significantly 
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higher than expected. In CT 2523, during 1996-2002, the incidence of brain cancer 
among males was statistically significantly elevated with five diagnoses observed 
when approximately two would be expected. In the earlier two time periods in CT 
2523, brain cancer incidence in males was about as expected during 1982-1988 and 
slightly higher than expected during 1989-1995, although not statistically 
significantly higher. 
•	 During 1996-2002, four diagnoses of childhood cancer occurred in children in CT 
2523 when approximately one would be expected. Three of the four children were 
diagnosed with brain cancer. Between 2003 and the present, one additional child 
has been diagnosed with brain cancer in CT 2523. The types of brain cancer varied 
among these four children. The age at diagnosis of the four children was consistent 
with what would be expected for the four subtypes of brain cancer. With one 
exception, the children who were diagnosed with brain cancer across 8 years did not 
live in close proximity to each other nor did their residences appear concentrated 
near any of the three sites. Two of the four children with brain cancer lived in close 
proximity to each other. However, based on limited opportunities for exposure and, 
given that no increased cancer risk was predicted assuming exposure to the highest 
detected concentrations of contaminants at the three sites, it does not appear that a 
common environmental factor is likely related to these diagnoses. 
•	 Except for CT 2523 in 1996-2002, childhood cancers occurred about as expected 
citywide and in Methuen’s census tracts. The types of cancers diagnosed were 
varied and the ages at diagnosis of these cancers were consistent with state and 
national trends. 
•	 The number of asthma-related hospitalizations was consistently lower for the city of 
Methuen during 1989-2002, including 1994, when the fire at 54 Osgood Street took 
place. 
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•	 It was not possible to quantify the incidence of the other diseases that were 
mentioned on the surveys provided with the request letter from concerned residents. 
However these diseases generally varied in nature and different risk factors were 
identified for each disease. There did not appear to be a common environmental risk 
factor for these diseases. 
ATSDR requires that one of five conclusion categories be used to summarize findings of 
a health consultation. These categories are as follows: (1) Urgent Public Health Hazard; 
(2) Public Health Hazard; (3) Indeterminate Public Health Hazard; (4) No Apparent 
Public Health Hazard; (5) No Public Health Hazard. A category is selected from site-
specific conditions such as the degree of public health hazard based on the presence and 
duration of human exposure, contaminant concentration, the nature of toxic effects 
associated with site-related contaminants, presence of physical hazards, and community 
health concerns. Therefore, based on MDPH’s evaluation of the available environmental 
data, the exposure pathway analysis, and risk factor information related to the cancer 
types evaluated in this analysis, ATSDR would classify 54 Osgood Street as posing no 
apparent public health hazard to the public in the past, present and future. Since 
contaminants detected in groundwater at the 4 Gleason Street and 254 Broadway sites 
could be drawn into potential future private wells, these sites would pose a public health 
hazard in the future should wells be installed in contaminated groundwater areas. 
XI. Recommendations 
•	 No specific pattern of brain or childhood cancer emerged that was statistically 
significant and persisted over time to suggest that a common environmental factor 
is likely related to the incidence of these cancers. In addition, no significant health 
risks were predicted upon review of the available environmental data for the three 
sites evaluated in this report. The MDPH recommends no further investigation of 
brain or childhood cancer in Methuen at this time. The BEH will, however, 
continue to monitor the incidence of brain cancer in Methuen and its census tracts 
using data routinely collected by the Massachusetts Cancer Registry. 
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•	 Upon request, the MDPH will be available to assist the Methuen Health 
Department in reviewing and/or modifying the testing and approval process 
currently in place for new well construction in the area of 4 Gleason Street and 
254 Broadway to ensure that contaminated groundwater from beneath the area is 
not consumed in the future as drinking water by nearby residents. 
XII. Public Health Action Plan 
The purpose of the Public Health Action Plan is to ensure that this health consultation not 
only identifies potential public health hazards, but also provides a plan of action designed 
to mitigate and prevent adverse health effects resulting from exposure to hazardous 
substances in the environment.  Included is a commitment on the part of ATSDR/MDPH 
to follow up on this plan to ensure that it is implemented.  The public health action to be 
implemented by ATSDR/MDPH is as follows:  MDPH will continue to monitor the 
incidence of brain cancer in Methuen and its census tracts using data collected routinely 
by the Massachusetts Cancer Registry. 
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This document was prepared by the Bureau of Environmental Health of the Massachusetts 
Department of Public Health. If you have any questions about this document, please contact 
Suzanne K. Condon, Director of BEH/MDPH at 250 Washington Street, 7th Floor, Boston, MA 
02108. 
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Table 1
 
Maximum concentrations of contaminants detected in groundwater samples at 4 Gleason Street
 
(samples taken from 1986 - 2005)
 
Contaminant Date of sample Descriptive location of sample Maximum concentration (ppb) Drinking water comparison value (ppb) 
1,2-Dichloroethane Mar-93 B-19D 2 
CREG = 
Intermediate EMEG (child) = 
Intermediate EMEG (adult) = 
U.S. EPA MCL & MDEP MMCL = 
0.4 
2,000 
7000 
5 
1,2-Dichloroethylene, cis- Apr-00 B-3 87 
Intermediate EMEG (child) = 
Intermediate EMEG (adult) = 
EPA LTHA = 
U.S. EPA MCL & MDEP MMCL = 
3,000 
10,000 
70 
70 
1,2-Dichloroethylene, trans- Mar-93 B-3 110 
Intermediate EMEG (child) = 
Intermediate EMEG (adult) = 
RMEG (child) = 
RMEG (adult) = 
U.S. EPA MCL & MDEP MMCL = 
2,000 
7,000 
200 
700 
100 
Methylene chloride Nov-86 B-2 and B-3 16 
Chronic EMEG (child) = 
Chronic EMEG (adult) = 
U.S. EPA MCL & CREG = 
600 
2,000 
5 
Tetrachloroethene Mar-93 B-13 56 
RMEG (child) = 
RMEG (adult) = 
EPA LTHA = 
U.S. EPA MCL & MDEP MMCL = 
100 
400 
10 
5 
Trichloroeththene Mar-93 B-17D 670 
EPA PRG = 
EPA RBC = 
EPA MCLG = 
U.S. EPA MCL & MDEP MMCL = 
0.028 
0.026 
0 
5 
Vinyl chloride Nov-86 B-3 11 
Chronic EMEG (child) = 
Chronic EMEG (adult) = 
CREG = 
U.S. EPA MCL & MDEP MMCL = 
30 
100 
0.03 
2 
Antimony Oct-92 B-2 and B-3 5 
RMEG (child) = 
RMEG (adult) = 
LTHA; U.S. EPA MCL & MCLG = 
4 
10 
6 
Arsenic Apr-00 B-3 35 
CREG = 
Chronic EMEG (child); RMEG (child) = 
Chronic EMEG (Adult), RMEG (adult) = 
U.S. EPA MCL & MDEP MMCL = 
0.02 
3 
10 
10 
Beryllium Oct-92 B-12 7 
Chronic EMEG (child); RMEG (child) = 
Chronic EMEG (Adult), RMEG (adult) = 
U.S. EPA MCL = 
20 
70 
4 
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Table 1 (cont.) 
Contaminant Date of sample Descriptive location of sample Maximum concentration (ppb) Drinking water comparison value (ppb) 
Cadmium Oct-92 B-12 50 
Chronic EMEG (child) = 
Chronic EMEG (adult) = 
RMEG (child) & US EPA MCL = 
RMEG (adult) = 
2 
7 
5 
20 
Chromium Oct-92 B-12 60 
Hexavalent Chromium: RMEG (child) = 
Hexavalent Chromium: RMEG (adult) = 
U.S. EPA MCL & MDEP MMCL = 
30 
100 
100 
Lead May-91 B-2 96 
MCLG = 
U.S. EPA MCL & MDEP MMCL** = 
0 
15 
Mercury Aug-06 B-5 6.82 
EPA PRG = 
U.S. EPA MCL & MDEP MMCL = 
11 
2 
ppb=parts per billion 
Data sources: 
CHE 1994, CHE 1995, TRC 2000, LFR 2003, LFR 2006 
Comparison values (source organization, reference): 
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR 2006a)
 
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2006a)
 
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR 2006a)
 
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it comes to environmental 
 
exposures). (ATSDR 2006a)
 
EPA PRG = EPA Region 9 Preliminary Remediation Goal for tap water (U.S. EPA 2004)
 
EPA RBC = EPA Region 3 Risk Based Concentration for tap water (U.S. EPA 2006a)
 
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without appreciable risk of
 
deleterious effects during a specified duration of exposure). (ATSDR 2006a)
 
MCLG = Maximum Contaminant Level Goal for drinking water (ATSDR 2006a)
 
MDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MDEP 2006a)
 
LTHA = Lifetime Health Advisory
 
** This is an action level.  Action must be taken if more than 10% of tap water samples exceed this value.
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Table 2
 
Maximum concentrations of contaminants detected in soil samples at 4 Gleason Street
 
(samples taken from 1992 - 2005)
 
Contaminant Date of sample Descriptive location of sample (depth in feet) Maximum concentration (ppm) Soil Background (ppm) Soil comparison value (ppm) 
Trichloroethylene Apr-00 B-8D (1-2) 88 (post-excavation = range 3.8 ­30) ---
EPA RBC (residential soil) 
EPA PRG (residential soil) 
MDEP S-1 Soil & GW-1 
= 1.6 
0.053 
= 0.3 
Benzo(a)anthracene Apr-00 B-24 (3-5) 41 (post-excavation = 2.1) 
0.005 - 0.02 (rural soil) 
0.169 - 59 (urban soil) 
EPA RBC (residential soil) = 0.87  
Benzo(b)fluoranthene Apr-00 B-24 (3-5) 46(post-excavation = 1.6) 
0.02 - 0.03 (rural soil) 
15 - 62 (urban soil) 
EPA RBC (residential soil) = 0.87 
Benzo(a)pyrene Apr-00 B-24 (3-5) 24(post-excavation = 1.9) 0.002 - 1.3 (rural soil) 
0.165 - 0.22 (urban soil) 
CREG 
EPA RBC (residential soil) 
= 0.1 
= 0.087 
Dibenzo(a,h)anthracene Apr-00 B-24 (3-5) 1.7(post-excavation = ND) --- EPA RBC (residential soil) = 0.087 
Indeno(1,2,3-cd)pyrene Apr-00 B-24 (3-5) 11 (post-excavation = 1.5) 
0.01 - 0.015 (rural soil) 
8-61 (urban soil) 
EPA RBC (residential soil) = 0.87 
C11-C22 Aromatics Apr-00 B-24 (3-5) 660 (post-excavation = 56) --- S-1 Soil & GW-1 = 200 
Arsenic Sept-92 and Apr-00 B-10 (5-7) and B-8D (1-2) 40 (post excavation = range 8.3 ­27) 7.4 (range: <0.1 - 73) 
Chronic EMEG; RMEG (child) 
Chronic EMEG; RMEG (adult) 
CREG 
= 20 
= 200 
= 0.5 
Chromium (total) Mar-93 P-8 (2-3) 2200 (post-excavation = 11 -33) 52 (range: 1 - 1,000) 
RMEG (child) (Cr VI) 
RMEG (adult) (Cr VI) 
EPA RBC (residential soil) (Cr VI) 
= 200 
= 2,000 
= 230 
Note: Post-excavation soil measurements include those areas surrounding the location of the maximum concentration measured. 
ppm=parts per million 
Data sources: 
CHE 1994, CHE 1995, TRC 2000, LFR 2003, LFR 2006 
Comparison values (source organization, reference): 
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR 2006b)
 
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2006b)
 
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR 2006b)
 
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it comes to environmental exposures). (ATSDR 2006b)
 
EPA PRG = EPA Region 9 Preliminary Remediation Goal for residential soil (U.S. EPA 2004)
 
EPA RBC = EPA Region 3 Risk Based Concentration for residential soil (U.S. EPA, U.S. EPA 2006a)
 
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without appreciable risk of deleterious effects during a
 
specified duration of exposure). (ATSDR 2006b)
 
S-1 Soil & GW-1 = MCP Method 1 soil category S-1 standards applicable to residential exposure scenarios. (MDEP 2006d)
 
Sources of background values: 
Estimated arithmetic mean for the Eastern United States (east of 96th meridian). (USGS 1984)
 
Range of background Soil Concentrations.  ATSDR Toxicological Profiles 2000 (on CD-ROM), Table 5-3. ATSDR 2005.  
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Table 3
 
Maximum concentrations of contaminants detected in groundwater samples at 254 Broadway
 
(samples taken 2002 & 2005)
 
Contaminant Date of sample Descriptive location of sample Maximum concentration (ppb) Drinking water comparison value (ppb) 
C5-C8 Aliphatics Apr-05 MW-3 2,300 MDEP GW-1 = 400 
C9-C10 Aromatics Apr-05 MW-3 5,300 MDEP GW-1 = 200 
Toluene Apr-05 MW-3 770 
Intermediate EMEG (child) = 
Intermediate EMEG (adult) = 
RMEG (child) = 
RMEG (adult) = 
EPA LTHA = 
MDEP MMCL = 
200 
700 
800 
3,000 
1,000 
1,000 
Naphthalene Apr-05 MW-3 140 
Intermediate EMEG (child) = 
Intermediate EMEG (adult) = 
RMEG (child) = 
RMEG (adult) = 
EPA LTHA = 
6,000 
20,000 
200 
700 
100 
ppb=parts per billion 
Data sources: 
LFR 2006 
Comparison values (source organization, reference): 
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR 2006a)
 
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it comes to environmental 
 
exposures). (ATSDR 2006a)
 
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without appreciable risk of
 
deleterious effects during a specified duration of exposure). (ATSDR 2006a)
 
MDEP MMCL = Massachusetts Department of Environmental Protection Massachusetts Maxiumum Contaminant Level for drinking water (MDEP 2006a )
 
MDEP GW-1 = Massachusetts Department of Environmental Protection Massachusetts standard for either potential current or future sources of drinking water (MDEP 2006d)
 
LTHA = Lifetime Health Advisory
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Table 4
 
Maximum concentrations of contaminants detected in soil samples at 254 Broadway
 
(samples taken from Pre-(2002) and Post- (2005) Excavation) 
 
Contaminant Date of sample Descriptive location of sample (Sample depth) Maximum concentration (ppm) Soil Background (ppm) Soil comparison value (ppm) 
1,2,4-Trimethylbenzene* Aug-05 LFR-7-N (10.5') 310 (post) --- EPA PRG (residential soil) = 52 
1,3,5-Trimethylbenzene* Aug-05 LFR-7-N (10.5') 110 (post) --- EPA PRG (residential soil) = 21 
p-isopropyltoluene* Aug-05 LFR-7-N (10.5') 4.5 (post) --- Comparison values not available 
Benzo(a)pyrene Aug-02 LFR B10 S-4 (12-16') 0.52 (pre) 0.002 - 1.3 (rural soil) 
0.165 - 0.22 (urban soil) 
CREG = 
EPA RBC (residential soil) = 
0.1 
0.087 
Arsenic Aug-02 LFR B10 S-4 (12-16') 3.9 (pre) 7.4 (range: <0.1 - 73) 
Chronic EMEG (child) = 
Chronic EMEG (adult) = 
RMEG (child) = 
RMEG (adult) = 
CREG = 
20 
200 
20 
200 
0.5 
C5-C8 Aliphatics † Aug-05 LFR-7-N (10.5') 190 (post) S-1 Soil & GW-1 = 100 
C9-C10 Aromatics † Aug-02 & Aug-05 LFR B9 S-3 (8-10') & LFR-7-N (10.5') 0.0444 (pre); 3,000 (post) S-1 Soil & GW-1 = 100 
ppm=parts per million
 
†Additional excavation was conducted to remove elevated concentrations of C5-C8 Aliphatics and C9-C10 Aromatics.  	
*Additional excavation was conducted to remove contamination at LFR-7-N in Sept. 2005 and although these contaminants were not reanalyzed, it appears that contamination was removed.
 
Sampling during Sept. 2005 confirmed that these contaminants were
 not detected following this second excavation. 
Data sources: 
 
LFR, 2006b. Release Abatement Measurement (RAM) Completion Report and Class A-2 Response Action Outcome (RAO), 254 Broadway, Methuen, Massachusetts
 
Comparison values (source organization, reference): 
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR 2006b)
 
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2006b)
 
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without appreciable risk of deleterious effects during a
 
specified duration of exposure). (ATSDR 2006b)
 
EPA PRG = EPA Region 9 Preliminary Remediation Goal for residential soil (U.S. EPA, U.S. EPA 2004)
 
EPA RBC = EPA Region 3 Risk Based Concentration for tap water (U.S. EPA, U.S. EPA 2006a)
 
S-1 Soil & GW-1 = MCP Method 1 soil category S-1 standards applicable to residential exposure scenarios. (MDEP 2006d)
 
Sources of background values: 
Estimated arithmetic mean for the Eastern United States (east of 96th meridian). (USGS 1984)
 
Range of background Soil Concentrations.  ATSDR Toxicological Profiles 2000 (on CD-ROM), Table 5-3. ATSDR 2005.  
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Table 5
 
Maximum concentrations of contaminants detected in soil samples around the 54 Osgood St. Property
 
(samples taken during response action activities 1994)
 
Contaminant Date of sample 
Unpaved lot south of Site 
(ppm) 
Restaurant parking lot 
west of Site (ppm) 
Spicket River bank 
southeast of site (ppm) 
Background Samples taken west of 
restaurant building (ppm) Soil comparison value (ppm) 
Copper Dec-94 90.4 19.8 1590 27 
Intermediate EMEG (child) 
Intermediate EMEG (adult) 
= 
= 
500 
7,000 
Cyanide Dec-94 ND ND ND ND 
RMEG (child) 
RMEG (adult) 
= 
= 
1,000 
10,000 
Lead Dec-94 39.2 97.6 166 620 EPA PRG (residential soil) = 400 
Nickel Dec-94 70.4 17.5 134 27 
RMEG (child) 
RMEG (adult) 
= 
= 
1,000 
10,000 
Zinc Dec-94 35.7 54.5 340 142 
Chronic & Intermediate EMEG; RMEG (child) 
Chronic & Intermediate EMEG; RMEG (adult) 
= 
= 
20,000 
200,000 
ppm=parts per million
 
Data sources: 
 
Masssachusetts Department of Environmental Protection (MDEP). 1995b.  Memorandum to the File, RTN 3-10447, METHUEN-Bullseye Facility.  Dated January 15, 1995.
 
Comparison values (source organization, reference): 
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2006b)
 
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR 2006b)
 
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children to environmental exposures). (ATSDR 2006b)
 
EPA PRG = EPA Region 9 Preliminary Remediation Goal for residential soil (U.S. EPA, U.S. EPA 2004)
 
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without appreciable risk of deleterious effects during a
 
specified duration of exposure). (ATSDR 2006b)
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TABLE 6
 
Brain Cancer Incidence
 
Methuen, Massachusetts
 
1982-1988
 
Census Tract Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
2521.01 3 1.6 NC NC NC -- 1 0.9 NC NC NC -- 2 0.8 NC NC NC --
2521.02 2 1.3 NC NC NC -- 1 0.7 NC NC NC -- 1 0.6 NC NC NC --
2522.01 1 1.3 NC NC NC -- 0 0.7 NC NC NC -- 1 0.6 NC NC NC --
2522.02 1 1.0 NC NC NC -- 1 0.6 NC NC NC -- 0 0.4 NC NC NC --
2523 2 2.7 NC NC NC -- 1 1.3 NC NC NC -- 1 1.4 NC NC NC --
2524 2 1.9 NC NC NC -- 1 0.9 NC NC NC -- 1 1.0 NC NC NC --
2525.01 2 1.9 NC NC NC -- 1 1.0 NC NC NC -- 1 0.9 NC NC NC --
2525.02 2 2.4 NC NC NC -- 1 1.3 NC NC NC -- 1 1.1 NC NC NC --
2526.01 7 2.0 347 * 139 714 -- 3 1.1 NC NC NC -- 4 0.9 NC NC NC --
2526.02 2 1.0 NC NC NC -- 2 0.6 NC NC NC -- 0 0.4 NC NC NC --
2526.03 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.4 NC NC NC --
City Total † 25 17.8 141 91 208 -- 12 9.3 129 66 225 -- 13 8.4 154 82 263 --
† Cases for which census tract designation was not possible are included in the city total. 
Note: SIRs are calculated based on the exact number of expected cases. 
Expected number of cases presented are rounded to the nearest tenth. 
SIRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of cases 95% CI = 95% Confidence Interval 
Exp = Expected number of cases NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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TABLE 7
 
Brain Cancer Incidence
 
Methuen, Massachusetts
 
1989-1995
 
Census Tract Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
2521.01 4 1.9 NC NC NC -- 2 1.0 NC NC NC -- 2 0.9 NC NC NC --
2521.02 4 1.5 NC NC NC -- 3 0.9 NC NC NC -- 1 0.7 NC NC NC --
2522.01 4 1.5 NC NC NC -- 4 0.8 NC NC NC -- 0 0.7 NC NC NC --
2522.02 1 1.2 NC NC NC -- 0 0.7 NC NC NC -- 1 0.5 NC NC NC --
2523 5 3.0 169 54 340 -- 3 1.5 NC NC NC -- 2 1.5 NC NC NC --
2524 1 2.0 NC NC NC -- 0 1.0 NC NC NC -- 1 1.0 NC NC NC --
2525.01 3 2.1 NC NC NC -- 3 1.1 NC NC NC -- 0 1.0 NC NC NC --
2525.02 5 2.6 192 62 449 -- 1 1.4 NC NC NC -- 4 1.2 NC NC NC --
2526.01 2 2.7 NC NC NC -- 0 1.5 NC NC NC -- 2 1.3 NC NC NC --
2526.02 0 1.3 NC NC NC -- 0 0.7 NC NC NC -- 0 0.5 NC NC NC --
2526.03 1 1.1 NC NC NC -- 0 0.6 NC NC NC -- 1 0.5 NC NC NC --
City Total 30 20.4 147 99 210 -- 16 10.9 146 83 237 -- 14 9.5 147 80 247 --
Note: SIRs are calculated based on the exact number of expected cases. 
Expected number of cases presented are rounded to the nearest tenth. 
SIRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of cases 95% CI = 95% Confidence Interval 
Exp = Expected number of cases NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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TABLE 8
 
Brain Cancer Incidence
 
Methuen, Massachusetts
 
1996-2002
 
Census Tract Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
2521.01 1 2.0 NC NC NC -- 0 1.1 NC NC NC -- 1 1.0 NC NC NC --
2521.02 3 1.8 NC NC NC -- 2 1.0 NC NC NC -- 1 0.8 NC NC NC --
2522.01 3 1.6 NC NC NC -- 1 0.9 NC NC NC -- 2 0.8 NC NC NC --
2522.02 1 1.4 NC NC NC -- 1 0.8 NC NC NC -- 0 0.6 NC NC NC --
2523 6 3.2 186 68 406 -- 5 1.6 312 * 101 728 -- 1 1.6 NC NC NC --
2524 0 1.7 NC NC NC -- 0 0.9 NC NC NC -- 0 0.8 NC NC NC --
2525.01 2 2.0 NC NC NC -- 1 1.0 NC NC NC -- 1 1.0 NC NC NC --
2525.02 4 2.9 NC NC NC -- 2 1.5 NC NC NC -- 2 1.4 NC NC NC --
2526.01 6 3.3 182 67 397 -- 3 1.8 NC NC NC -- 3 1.5 NC NC NC --
2526.02 3 1.6 NC NC NC -- 1 0.9 NC NC NC -- 2 0.7 NC NC NC --
2526.03 0 1.3 NC NC NC -- 0 0.7 NC NC NC -- 0 0.6 NC NC NC --
City Total 29 22.7 128 85 183 -- 16 12.0 133 76 215 -- 13 10.7 122 65 208 --
Note: SIRs are calculated based on the exact number of expected cases. 
Expected number of cases presented are rounded to the nearest tenth. 
SIRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of cases 95% CI = 95% Confidence Interval 
Exp = Expected number of cases NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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TABLE 9
 
Childhood Cancer Incidence
 
Methuen, Massachusetts
 
1982-1988
 
Census Tract Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
2521.01 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.4 NC NC NC --
2521.02 1 0.9 NC NC NC -- 1 0.5 NC NC NC -- 0 0.4 NC NC NC --
2522.01 3 1.0 NC NC NC -- 1 0.5 NC NC NC -- 2 0.5 NC NC NC --
2522.02 2 0.8 NC NC NC -- 1 0.5 NC NC NC -- 1 0.4 NC NC NC --
2523 0 1.6 NC NC NC -- 0 0.9 NC NC NC -- 0 0.8 NC NC NC --
2524 1 1.9 NC NC NC -- 0 1.0 NC NC NC -- 1 0.9 NC NC NC --
2525.01 2 0.9 NC NC NC -- 2 0.5 NC NC NC -- 0 0.4 NC NC NC --
2525.02 0 1.2 NC NC NC -- 0 0.6 NC NC NC -- 0 0.5 NC NC NC --
2526.01 0 1.2 NC NC NC -- 0 0.7 NC NC NC -- 0 0.6 NC NC NC --
2526.02 2 0.8 NC NC NC -- 1 0.4 NC NC NC -- 1 0.4 NC NC NC --
2526.03 0 0.6 NC NC NC -- 0 0.3 NC NC NC -- 0 0.3 NC NC NC --
City Total † 11 11.4 96 48 172 -- 6 6.2 97 35 211 -- 5 5.3 95 31 222 --
† Cases for which census tract designation was not possible are included in the city total. 
Note: SIRs are calculated based on the exact number of expected cases. 
Expected number of cases presented are rounded to the nearest tenth. 
SIRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of cases 95% CI = 95% Confidence Interval 
Exp = Expected number of cases NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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TABLE 10
 
Childhood Cancer Incidence
 
Methuen, Massachusetts
 
1989-1995
 
Census Tract Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
2521.01 1 0.8 NC NC NC -- 1 0.5 NC NC NC -- 0 0.3 NC NC NC --
2521.02 1 1.0 NC NC NC -- 1 0.6 NC NC NC -- 0 0.4 NC NC NC --
2522.01 3 0.9 NC NC NC -- 3 0.5 NC NC NC -- 0 0.5 NC NC NC --
2522.02 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.3 NC NC NC --
2523 2 1.5 NC NC NC -- 1 0.9 NC NC NC -- 1 0.7 NC NC NC --
2524 2 2.3 NC NC NC -- 1 1.3 NC NC NC -- 1 1.0 NC NC NC --
2525.01 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.4 NC NC NC --
2525.02 3 1.1 NC NC NC -- 1 0.6 NC NC NC -- 2 0.5 NC NC NC --
2526.01 0 1.4 NC NC NC -- 0 0.8 NC NC NC -- 0 0.6 NC NC NC --
2526.02 1 1.0 NC NC NC -- 0 0.5 NC NC NC -- 1 0.5 NC NC NC --
2526.03 0 0.7 NC NC NC -- 0 0.4 NC NC NC -- 0 0.3 NC NC NC --
City Total † 13 11.9 109 58 186 -- 8 6.7 119 51 234 -- 5 5.2 96 31 224 --
† Cases for which census tract designation was not possible are included in the city total. 
Note: SIRs are calculated based on the exact number of expected cases. 
Expected number of cases presented are rounded to the nearest tenth. 
SIRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of cases 95% CI = 95% Confidence Interval 
Exp = Expected number of cases NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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TABLE 11
 
Childhood Cancer Incidence
 
Methuen, Massachusetts
 
1996-2002
 
Census Tract Total Males Females 
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI 
2521.01 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.4 NC NC NC --
2521.02 3 1.2 NC NC NC -- 2 0.7 NC NC NC -- 1 0.5 NC NC NC --
2522.01 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.4 NC NC NC --
2522.02 1 1.1 NC NC NC -- 0 0.6 NC NC NC -- 1 0.5 NC NC NC --
2523 5 1.6 309 100 723 -- 4 0.9 NC NC NC -- 1 0.7 NC NC NC --
2524 0 1.8 NC NC NC -- 0 1.0 NC NC NC -- 0 0.8 NC NC NC --
2525.01 1 1.0 NC NC NC -- 1 0.5 NC NC NC -- 0 0.5 NC NC NC --
2525.02 1 1.2 NC NC NC -- 0 0.6 NC NC NC -- 1 0.5 NC NC NC --
2526.01 0 1.7 NC NC NC -- 0 0.9 NC NC NC -- 0 0.8 NC NC NC --
2526.02 1 1.2 NC NC NC -- 1 0.7 NC NC NC -- 0 0.6 NC NC NC --
2526.03 0 0.9 NC NC NC -- 0 0.5 NC NC NC -- 0 0.4 NC NC NC --
City Total † 12 13.4 90 46 157 -- 8 7.2 111 48 219 -- 4 6.2 NC NC NC --
† Cases for which census tract designation was not possible are included in the city total. 
Note: SIRs are calculated based on the exact number of expected cases. 
Expected number of cases presented are rounded to the nearest tenth. 
SIRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of cases 95% CI = 95% Confidence Interval 
Exp = Expected number of cases NC = Not calculated 
SIR = Standardized Incidence Ratio * = Statistical significance 
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health. 
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TABLE 12
 
Asthma Hospitalizations by Year
 
Methuen, Massachusetts
 
Year Total Males Females 
Obs Exp SHR 95% CI Obs Exp SHR 95% CI Obs Exp SHR 95% CI 
1989 164 174.7 94 80 109 -- 72 67.4 107 84 134 -- 92 107.6 86 69 105 --
1990 165 187.9 88 75 102 -- 70 71.4 98 76 124 -- 95 117.0 81 * 66 99 --
1991 213 209.7 102 88 116 -- 83 80.3 103 82 128 -- 130 129.9 100 84 119 --
1992 196 217.3 90 78 104 -- 79 81.3 97 77 121 -- 117 136.2 86 71 103 --
1993 233 238.1 98 86 111 -- 94 88.3 107 86 130 -- 139 150.0 93 78 109 --
1994 176 212.5 83 * 71 96 -- 74 75.1 98 77 124 -- 102 137.3 74 * 61 90 --
1995 163 212.5 77 * 65 89 -- 54 73.5 74 * 55 96 -- 109 138.9 78 * 64 95 --
1996 163 217.1 75 * 64 88 -- 70 73.3 96 74 121 -- 93 143.7 65 * 52 79 --
1997 195 221.2 88 76 101 -- 61 74.7 82 62 105 -- 134 146.2 92 77 109 --
1998 222 227.8 97 85 111 -- 83 74.7 111 89 138 -- 139 152.8 91 76 107 --
1999 179 244.6 73 * 63 85 -- 50 79.2 63 * 47 83 -- 129 165.5 78 * 65 93 --
2000 190 268.6 71 * 61 82 -- 42 86.1 49 * 35 66 -- 148 183.1 81 * 68 95 --
2001 217 288.4 75 * 66 86 -- 71 92.3 77 * 60 97 -- 146 196.9 74 * 63 87 --
2002 233 310.5 75 * 66 85 -- 77 101.7 76 * 60 95 -- 156 209.5 74 * 63 87 --
Note: SHRs are calculated based on the exact number of expected hospital visits 
Expected number of hospital visits presented are rounded to the nearest tenth. 
SHRs and 95% CI are not calculated when observed number of cases < 5. 
Obs = Observed number of hospital visits 95% CI = 95% Confidence Interval 
Exp = Expected number of hospital visits NC = Not calculated 
SHR = Standardized Hospitalization Ratio * = Statistical significance 
Data Source: Massachusetts Division of Health Care Finance and Policy, Inpatient Hospital Discharge Database. 
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Appendix A 
Site Inventory List 
 
Precise Circuit/Bullseye Facility  
 
Methuen, Massachusetts
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Site Inventory List 
 
Precise Circuit/Bullseye Facility
 
Methuen, Massachusetts
 
Number of Drums Contents of Drums 
2 Waste Ammonium Hydroxide & Water 
1 Waste Sulfuric Acid & Water 
2 Waste Potassium Hydroxide 
6 Non-Hazardous Wastewater 
15 Metal Hydroxide Solids 
9 Fluoboric Acid/Nitric Acid 
3 Hydrochloric Acid 
5  Waste Oil  
4 Hazardous Liquid 
1  Nitric Acid  
1 Speedy Dry with Ammonia 
Source: Emergency Response Documentation Report, Precise Circuit/Bullseye Facility
 
Methuen, MA, 15-19 January 1994.  Prepared by Roy F. Weston, Inc.
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Appendix B 
Cancer Incidence Coding Definitions 
84 
 
APPENDIX B 

ICD CODES USED FOR THIS REPORT 

Cancer Site / Type 
Brain & Other Nervous System 
Breast 
Bronchus & Lung 
Cervix Uteri 
Colon/Rectum 
Corpus Uteri & Uterus, NOS 
Esophagus 
Hodgkin's Disease 
(Hodgkin Lymphoma) 
Kidney & Renal Pelvis 
Larynx 
Leukemia 
Liver and Intrahepatic Bile Ducts 
Melanoma of Skin 
Multiple Myeloma 
Non-Hodgkin('s) 
Lymphoma 
ICD-O-32 
Primary Site Codes 
C70.0 - C72.9 
C50.0 - C50.9 
C34.0 - C34.9 
C53.0 - C53.9 
C18.0 - C18.9, C19.9, C20.9, 
C26.0 
C54.0 - C54.9, C55.9 
C15.0 - C15.9 
C00.0 - C80.9 
C64.9, C65.9 
C32.0 - C32.9 
C00.0 - C80.9 
C42.0, C42.1, C42.4 
C22.0, C22.1 
C44.0 - C44.9 
C00.0 - C80.9 
C00.0 - C80.9 
all sites except C42.0, C42.1, 
C42.4 
Histology Type Codes3 
all except 9590 - 9989 

all except 9590 - 9989 

all except 9590 - 9989 

all except 9590 - 9989 

all except 9590 - 9989 

all except 9590 - 9989 

all except 9590 - 9989 

includes 9650 – 9667 

all except 9590 - 9989 

all except 9590 - 9989 

includes 9733, 9742,   

9800-9820, 9826, 9831­

9948, 9963-9964 

includes 9823, 9827 

all except 9590 - 9989 

includes 8720 - 8790 

includes 9731, 9732, 

9734 

includes 9590 - 9595, 

9670 – 9729 

includes 9823, 9827 

2 International Classification of Diseases for Oncology, 3d Ed. (2) (includes codes added since publication) 
3 Only invasive cancers (those with invasive behaviors) are included in this report. 
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Cancer Site / Type ICD-O-3
 
Primary Site Codes Histologic Type Codes 
 
Multiple Myeloma C00.0 - C80.9 includes 9731, 9732, 
 
9734 
 
Non-Hodgkin('s) C00.0 - C80.9 includes 9590 - 9595, 
 
Lymphoma 9670 – 9729 
 
all sites except C42.0, C42.1, includes 9823, 9827 
 
C42.4 
 
Oral Cavity C00.0 - C14.8 all except 9590 - 9989 
 
& Pharynx 
 
Ovary C56.9 all except 9590 - 9989 
 
Pancreas C25.0 - C25.9 all except 9590 - 9989 
 
Prostate C61.9 all except 9590 - 9989 
 
Stomach C16.0 - C16.9 all except 9590 - 9989 
 
Testis C62.0 - C62.9 all except 9590 - 9989 
 
Thyroid C73.9 all except 9590 - 9989 
 
Urinary Bladder C67.0 - C67.9 all except 9590 - 9989 
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Risk Factor Information for Brain and Central Nervous System Cancers 
Brain and central nervous system (CNS) tumors can be either malignant (cancerous) or 
benign (non-cancerous). Primary brain tumors (i.e., brain cancer) comprise two main 
types: gliomas and malignant meningiomas. Gliomas are a general classification of 
malignant tumors that include a variety of types, named for the cells from which they 
arise: astrocytomas, oligodendrogliomas, and ependymomas. Meningiomas arise from the 
meninges, which are tissues that surround the outer part of the spinal cord and brain. 
Although meningiomas are not technically brain tumors, as they occur outside of the 
brain, they account for about 25% of all reported primary brain tumors and the majority 
of spinal cord tumors. The majority of meningiomas (about 85%) are benign and can be 
cured by surgery. In addition to these main types, there are a number of rare brain tumors, 
including medulloblastomas, which develop from the neurons of the cerebellum and are 
most often seen in children. Also, the brain is a site where both primary and secondary 
malignant tumors can arise; secondary brain tumors generally originate elsewhere in the 
body and then metastasize, or spread, to the brain (ACS 2006a). The American Cancer 
Society estimates that 18,820 Americans (10,730 men and 8,090 women) will be 
diagnosed with primary brain cancer (including cancers of the central nervous system, or 
spinal cord) and approximately 12,820 people (7,260 men and 5,560 women) will die 
from this disease in 2006 (ACS 2006). 
Brain and spinal cord cancers account for over 20% of malignant tumors diagnosed 
among children aged 0-14 (ACS 2006b). About half of all childhood brain tumors are 
astrocytomas and 25% are primitive neuroectodermal tumors (PNET), which spread 
along the spinal cord and the meninges (ACS 2006b). After a peak in incidence during 
childhood (generally under 10 years of age), the risk of brain cancer increases with age 
from age 25 to age 75. In adults, the most frequent types of brain tumors are astrocytic 
tumors (mainly astrocytomas and glioblastoma multiforme). Incidence rates are higher in 
males than in females for all types. In general, the highest rates of brain and nervous 
system cancer tend to occur in whites. However, this varies somewhat by type; the 
incidence of gliomas is lower among black men and women than whites, but for 
meningiomas, the reverse is true (Preston-Martin and Mack 1996). 
Despite numerous scientific and medical investigations, and analyses, the causes of brain 
cancer are still largely unknown. Among the possible risk factors investigated in relation 
to this type of cancer are ionizing radiation, electromagnetic fields, occupational 
exposures, exposure to N-nitroso compounds, head trauma, and genetic disorders. 
The most established risk factor (and only established environmental risk factor) for brain 
tumors (either cancerous or non-cancerous) is high-dose exposure to ionizing radiation 
(i.e., x-rays and gamma rays). Most radiation-induced brain tumors are caused by 
radiation to the head from the treatment of other cancers (ACS 2006a). Meningiomas are 
the most common type of tumors that occur from this type of exposure, but gliomas may 
also occur (Preston-Martin and Mack 1996). Among adults, the risk of developing 
meningiomas has been associated with full-mouth dental x-rays taken decades ago when 
radiation doses were higher than today. Although the relationship between low-dose 
radiation exposure and increased risk of brain tumors has been debated in several studies, 
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prenatal exposure from diagnostic x-rays has been related to an increase in childhood 
brain tumors (Preston-Martin and Mack 1996). 
In recent years, there has been increasing public concern and scientific interest regarding 
the relationship of electromagnetic fields (EMF) to brain cancer. However, results from 
recent epidemiological investigations provide little or no evidence of an association 
between residential EMF exposure (e.g., from power lines and home appliances) and 
brain tumors (Kheifets 2001). Studies also suggest that the use of handheld cellular 
telephones is not associated with an increased risk of primary brain cancer (Muscat et al. 
2000). However, given the relatively recent use of cellular phones, evidence is 
preliminary and few studies have been conducted. 
Other environmental factors such as exposure to vinyl chloride (used in the 
manufacturing of some plastics) and aspartame (a sugar substitute) have been suggested 
as possible risk factors for brain cancer but no conclusive evidence exists implicating 
these factors (ACS 2006a). Although some occupational studies have suggested that 
electrical and electric utility workers may be at a slightly increased risk of brain cancer, 
these studies have important limitations, such as exposure misclassifications and a lack of 
dose-response relationships (Kheifets 2001). Some researchers have also reported an 
increased risk of brain tumors in adults among veterinarians and farmers. Exposures to 
farm animals and pets have been considered as possible risk factors because of their 
association with bacteria, pesticides, solvents, and certain animal oncogenic (cancer­
related) viruses (Yeni-Komshian and Holly 2000). However, the relationship between 
farm life and brain cancer remains controversial. 
Recent reports have proposed a link between occupational exposure to lead and brain 
cancer risk, but further analytic studies are warranted to test this hypothesis (Cocco et al. 
1998). In a case-control study, the concentrations of metal and non-metal compounds in 
brain biopsies from patients with primary brain tumors were compared to results from an 
analysis of tumor-free brain tissue. Statistically significant associations were observed 
between the presence of brain tumors and the concentrations of silicon, magnesium, and 
calcium (Hadfield et al. 1998). However, further research using a larger sample size is 
needed to determine whether exposure to these elements plays a role in the development 
of brain cancer. Other occupations that may be associated with elevated risks include 
workers in certain health professions (e.g., pathologists and physicians), agricultural 
workers, workers in the nuclear industry, and workers in the rubber industry, although 
specific exposures have not been established (Preston-Martin and Mack 1996). Studies 
investigating the possible association between occupational exposure of parents (in 
particular, paper or pulp-mill, aircraft, rubber, metal, construction, and electric workers) 
and the onset of brain tumors in their children have provided inconsistent results 
(Preston-Martin and Mack 1996). 
The association between the development of brain cancer and nitrites and other N-nitroso 
compounds, among the most potent of carcinogens, has been heavily researched. N­
nitroso compounds have been found in tobacco smoke, cosmetics, automobile interiors, 
and cured meats. A study concluded that an increased risk of pediatric brain tumor may 
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be associated with high levels of nitrite intake from maternal cured meat consumption 
during pregnancy (Pogoda and Preston-Martin 2001). However, the role of nitrites and 
cured meats in the development of brain cancer remains controversial (Blot et al. 1999; 
Bunin 2000). Because most people have continuous, low level exposure to N-nitroso 
compounds throughout their lives, further studies, especially cohort studies, are needed to 
determine if this exposure leads to an increased risk of brain tumors (Preston-Martin 
1996). 
Injury to the head has been suggested as a possible risk factor for later development of 
brain tumors but most researchers agree that there is no conclusive evidence for an 
association (ACS 2006a). Head trauma is most strongly associated with the development 
of meningiomas compared with other types of brain tumor. Several studies have found an 
increased risk in women with histories of head trauma; in men who boxed; and in men 
with a previous history of head injuries. Gliomas are the most common type of childhood 
brain tumor and have been positively associated with trauma at birth (e.g., Cesarean 
section, prolonged labor, and forceps delivery). However, other studies have found no 
association (Preston-Martin and Mack 1996). 
In addition, rare cases of brain and spinal cord cancer run in some families. Brain tumors 
in some persons are associated with genetic disorders such as neurofibromatosis types I 
and II, Li-Fraumeni syndrome, and tuberous sclerosis. Neurofibromatosis type I (von 
Recklinghausen’s disease) is the most common inherited cause of brain or spinal cord 
tumors and occurs in about one out of every 3,000 people (Preston-Martin and Mack 
1996). The disease may be associated with optic gliomas or other gliomas of the brain or 
spinal cord (ACS 2006b). Of those afflicted with the disease, about 5-10% will develop a 
central nervous system tumor (Preston-Martin and Mack 1996). In addition, von Hippell-
Lindau disease is associated with an inherited tendency to develop blood vessel tumors of 
the cerebellum (ACS 2006b). However, malignant (or cancerous) brain tumors are rare in 
these disorders; inherited syndromes that predispose individuals to brain tumors appear to 
be present in fewer than 5% of brain tumor patients (Preston-Martin and Mack 1996). 
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ATSDR Glossary of Terms 
 
The Agency for Toxic Substances and Disease Registry (ATSDR) is a federal public health 
agency with headquarters in Atlanta, Georgia, and 10 regional offices in the United States. 
ATSDR's mission is to serve the public by using the best science, taking responsive public health 
actions, and providing trusted health information to prevent harmful exposures and diseases 
related to toxic substances. ATSDR is not a regulatory agency, unlike the U.S. Environmental 
Protection Agency (EPA), which is the federal agency that develops and enforces environmental 
laws to protect the environment and human health. This glossary defines words used by ATSDR 
in communications with the public. It is not a complete dictionary of environmental health terms. 
If you have questions or comments, call ATSDR's toll-free telephone number, 1-888-42-ATSDR 
(1-888-422-8737). 
General Terms 
Absorption 
The process of taking in. For a person or an animal, absorption is the process of a substance 
getting into the body through the eyes, skin, stomach, intestines, or lungs.  
Acute 
Occurring over a short time [compare with chronic].  
Acute exposure 
Contact with a substance that occurs once or for only a short time (up to 14 days) [compare with 
intermediate duration exposure and chronic exposure].  
Additive effect 
A biologic response to exposure to multiple substances that equals the sum of responses of all the 
individual substances added together [compare with antagonistic effect and synergistic effect].  
Adverse health effect 
A change in body function or cell structure that might lead to disease or health problems 
Aerobic 
Requiring oxygen [compare with anaerobic].  
Ambient 
Surrounding (for example, ambient air).  
Anaerobic 
Requiring the absence of oxygen [compare with aerobic].  
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Analyte 
A substance measured in the laboratory. A chemical for which a sample (such as water, air, or 
blood) is tested in a laboratory. For example, if the analyte is mercury, the laboratory test will 
determine the amount of mercury in the sample.  
Analytic epidemiologic study  
A study that evaluates the association between exposure to hazardous substances and disease by 
testing scientific hypotheses. 
Antagonistic effect 
A biologic response to exposure to multiple substances that is less than would be expected if the 
known effects of the individual substances were added together [compare with additive effect 
and synergistic effect]. 
Background level 
An average or expected amount of a substance or radioactive material in a specific environment, 
or typical amounts of substances that occur naturally in an environment.  
Biodegradation 
Decomposition or breakdown of a substance through the action of microorganisms (such as 
bacteria or fungi) or other natural physical processes (such as sunlight).  
Biologic indicators of exposure study  
A study that uses (a) biomedical testing or (b) the measurement of a substance [an analyte], its 
metabolite, or another marker of exposure in human body fluids or tissues to confirm human 
exposure to a hazardous substance [also see exposure investigation].  
Biologic monitoring 
Measuring hazardous substances in biologic materials (such as blood, hair, urine, or breath) to 
determine whether exposure has occurred. A blood test for lead is an example of biologic 
monitoring. 
Biologic uptake  
The transfer of substances from the environment to plants, animals, and humans.  
Biomedical testing 
Testing of persons to find out whether a change in a body function might have occurred because 
of exposure to a hazardous substance. 
Biota 
Plants and animals in an environment. Some of these plants and animals might be sources of 
food, clothing, or medicines for people.  
Body burden  
The total amount of a substance in the body. Some substances build up in the body because they 
are stored in fat or bone or because they leave the body very slowly.  
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CAP [see Community Assistance Panel.]  
Cancer 
Any one of a group of diseases that occur when cells in the body become abnormal and grow or 
multiply out of control.  
Cancer risk 
A theoretical risk for getting cancer if exposed to a substance every day for 70 years (a lifetime 
exposure). The true risk might be lower.  
Carcinogen 
A substance that causes cancer. 
Case study 
A medical or epidemiologic evaluation of one person or a small group of people to gather 
information about specific health conditions and past exposures.  
Case-control study 
A study that compares exposures of people who have a disease or condition (cases) with people 
who do not have the disease or condition (controls). Exposures that are more common among the 
cases may be considered as possible risk factors for the disease.  
CAS registry number 
A unique number assigned to a substance or mixture by the American Chemical Society 
Abstracts Service. 
Central nervous system 
The part of the nervous system that consists of the brain and the spinal cord.  
CERCLA [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980] 
Chronic 
Occurring over a long time [compare with acute].  
Chronic exposure 
Contact with a substance that occurs over a long time (more than 1 year) [compare with acute 
exposure and intermediate duration exposure]  
Cluster investigation 
A review of an unusual number, real or perceived, of health events (for example, reports of 
cancer) grouped together in time and location. Cluster investigations are designed to confirm 
case reports; determine whether they represent an unusual disease occurrence; and, if possible, 
explore possible causes and contributing environmental factors.  
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Community Assistance Panel (CAP)  
A group of people from a community and from health and environmental agencies who work 
with ATSDR to resolve issues and problems related to hazardous substances in the community. 
CAP members work with ATSDR to gather and review community health concerns, provide 
information on how people might have been or might now be exposed to hazardous substances, 
and inform ATSDR on ways to involve the community in its activities.  
Comparison value (CV) 
Calculated concentration of a substance in air, water, food, or soil that is unlikely to cause 
harmful (adverse) health effects in exposed people. The CV is used as a screening level during 
the public health assessment process. Substances found in amounts greater than their CVs might 
be selected for further evaluation in the public health assessment process.  
Completed exposure pathway [see exposure pathway]. 
Comprehensive Environmental Response, Compensation, and Liability Act of 1980 
(CERCLA) 
CERCLA, also known as Superfund, is the federal law that concerns the removal or cleanup of 
hazardous substances in the environment and at hazardous waste sites. ATSDR, which was 
created by CERCLA, is responsible for assessing health issues and supporting public health 
activities related to hazardous waste sites or other environmental releases of hazardous 
substances. This law was later amended by the Superfund Amendments and Reauthorization Act 
(SARA). 
Concentration 
The amount of a substance present in a certain amount of soil, water, air, food, blood, hair, urine, 
breath, or any other media.  
Contaminant 
A substance that is either present in an environment where it does not belong or is present at 
levels that might cause harmful (adverse) health effects.  
Delayed health effect 
A disease or an injury that happens as a result of exposures that might have occurred in the past.  
Dermal 
Referring to the skin. For example, dermal absorption means passing through the skin.  
Dermal contact  
Contact with (touching) the skin [see route of exposure]. 
Descriptive epidemiology  
The study of the amount and distribution of a disease in a specified population by person, place, 
and time.  
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Detection limit 
The lowest concentration of a chemical that can reliably be distinguished from a zero 
concentration.  
Disease prevention 
Measures used to prevent a disease or reduce its severity.  
Disease registry  
A system of ongoing registration of all cases of a particular disease or health condition in a 
defined population. 
DOD 
United States Department of Defense.  
DOE 
United States Department of Energy.  
 
Dose (for chemicals that are not radioactive)  
 
The amount of a substance to which a person is exposed over some time period. Dose is a 
 
measurement of exposure. Dose is often expressed as milligram (amount) per kilogram (a 
 
measure of body weight) per day (a measure of time) when people eat or drink contaminated 
 
water, food, or soil. In general, the greater the dose, the greater the likelihood of an effect. An 
 
"exposure dose" is how much of a substance is encountered in the environment. An "absorbed 
 
dose" is the amount of a substance that actually got into the body through the eyes, skin, 
 
stomach, intestines, or lungs.  
 
Dose (for radioactive chemicals)  
 
The radiation dose is the amount of energy from radiation that is actually absorbed by the body. 
 
This is not the same as measurements of the amount of radiation in the environment.  
 
Dose-response relationship  
The relationship between the amount of exposure [dose] to a substance and the resulting changes 
in body function or health (response). 
Environmental media 
Soil, water, air, biota (plants and animals), or any other parts of the environment that can contain 
contaminants.  
Environmental media and transport mechanism  
Environmental media include water, air, soil, and biota (plants and animals). Transport 
mechanisms move contaminants from the source to points where human exposure can occur. The 
environmental media and transport mechanism is the second part of an exposure pathway.  
EPA 
United States Environmental Protection Agency.  
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Epidemiologic surveillance [see Public health surveillance]. 
Epidemiology  
The study of the distribution and determinants of disease or health status in a population; the 
study of the occurrence and causes of health effects in humans.  
Exposure 
Contact with a substance by swallowing, breathing, or touching the skin or eyes. Exposure may 
be short-term [acute exposure], of intermediate duration, or long-term [chronic exposure].  
Exposure assessment 
The process of finding out how people come into contact with a hazardous substance, how often 
and for how long they are in contact with the substance, and how much of the substance they are 
in contact with.  
Exposure-dose reconstruction 
A method of estimating the amount of people's past exposure to hazardous substances. Computer 
and approximation methods are used when past information is limited, not available, or missing.  
Exposure investigation 
The collection and analysis of site-specific information and biologic tests (when appropriate) to 
determine whether people have been exposed to hazardous substances.  
Exposure pathway  
The route a substance takes from its source (where it began) to its end point (where it ends), and 
how people can come into contact with (or get exposed to) it. An exposure pathway has five 
parts: a source of contamination (such as an abandoned business); an environmental media and 
transport mechanism (such as movement through groundwater); a point of exposure (such as a 
private well); a route of exposure (eating, drinking, breathing, or touching), and a receptor 
population (people potentially or actually exposed). When all five parts are present, the exposure 
pathway is termed a completed exposure pathway.  
Exposure registry 
A system of ongoing followup of people who have had documented environmental exposures.  
Feasibility study  
A study by EPA to determine the best way to clean up environmental contamination. A number 
of factors are considered, including health risk, costs, and what methods will work well.  
Geographic information system (GIS)  
A mapping system that uses computers to collect, store, manipulate, analyze, and display data. 
For example, GIS can show the concentration of a contaminant within a community in relation to 
points of reference such as streets and homes.  
Grand rounds 
Training sessions for physicians and other health care providers about health topics.  
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Groundwater  
Water beneath the earth's surface in the spaces between soil particles and between rock surfaces 
[compare with surface water].  
Half-life (t½)  
The time it takes for half the original amount of a substance to disappear. In the environment, the 
half-life is the time it takes for half the original amount of a substance to disappear when it is 
changed to another chemical by bacteria, fungi, sunlight, or other chemical processes. In the 
human body, the half-life is the time it takes for half the original amount of the substance to 
disappear, either by being changed to another substance or by leaving the body. In the case of 
radioactive material, the half life is the amount of time necessary for one half the initial number 
of radioactive atoms to change or transform into another atom (that is normally not radioactive). 
After two half lives, 25% of the original number of radioactive atoms remain.  
Hazard  
A source of potential harm from past, current, or future exposures.  
Hazardous Substance Release and Health Effects Database (HazDat)  
The scientific and administrative database system developed by ATSDR to manage data 
collection, retrieval, and analysis of site-specific information on hazardous substances, 
community health concerns, and public health activities.  
Hazardous waste  
Potentially harmful substances that have been released or discarded into the environment.  
Health consultation 
A review of available information or collection of new data to respond to a specific health 
question or request for information about a potential environmental hazard. Health consultations 
are focused on a specific exposure issue. Health consultations are therefore more limited than a 
public health assessment, which reviews the exposure potential of each pathway and chemical 
[compare with public health assessment].  
Health education 
Programs designed with a community to help it know about health risks and how to reduce these 
risks. 
Health investigation 
The collection and evaluation of information about the health of community residents. This 
information is used to describe or count the occurrence of a disease, symptom, or clinical 
measure and to evaluate the possible association between the occurrence and exposure to 
hazardous substances. 
Health promotion 
The process of enabling people to increase control over, and to improve, their health.  
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Health statistics review 
The analysis of existing health information (i.e., from death certificates, birth defects registries, 
and cancer registries) to determine if there is excess disease in a specific population, geographic 
area, and time period. A health statistics review is a descriptive epidemiologic study.  
Indeterminate public health hazard 
The category used in ATSDR's public health assessment documents when a professional 
judgment about the level of health hazard cannot be made because information critical to such a 
decision is lacking. 
Incidence 
The number of new cases of disease in a defined population over a specific time period [contrast 
with prevalence]. 
Ingestion 
The act of swallowing something through eating, drinking, or mouthing objects. A hazardous 
substance can enter the body this way [see route of exposure].  
Inhalation 
The act of breathing. A hazardous substance can enter the body this way [see route of exposure].  
Intermediate duration exposure  
Contact with a substance that occurs for more than 14 days and less than a year [compare with 
acute exposure and chronic exposure]. 
In vitro 
In an artificial environment outside a living organism or body. For example, some toxicity 
testing is done on cell cultures or slices of tissue grown in the laboratory, rather than on a living 
animal [compare with in vivo].  
In vivo 
Within a living organism or body. For example, some toxicity testing is done on whole animals, 
such as rats or mice [compare with in vitro].  
Lowest-observed-adverse-effect level (LOAEL)  
The lowest tested dose of a substance that has been reported to cause harmful (adverse) health 
effects in people or animals. 
Medical monitoring  
A set of medical tests and physical exams specifically designed to evaluate whether an 
individual's exposure could negatively affect that person's health.  
Metabolism 
The conversion or breakdown of a substance from one form to another by a living organism.  
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Metabolite 
Any product of metabolism. 
mg/kg 
Milligram per kilogram.  
mg/cm2 
Milligram per square centimeter (of a surface).  
mg/m3 
Milligram per cubic meter; a measure of the concentration of a chemical in a known volume (a 
cubic meter) of air, soil, or water.  
Migration 
Moving from one location to another. 
Minimal risk level (MRL)  
An ATSDR estimate of daily human exposure to a hazardous substance at or below which that 
substance is unlikely to pose a measurable risk of harmful (adverse), non-cancerous effects. 
MRLs are calculated for a route of exposure (inhalation or oral) over a specified time period 
(acute, intermediate, or chronic). MRLs should not be used as predictors of harmful (adverse) 
health effects [see reference dose]. 
Morbidity 
State of being ill or diseased. Morbidity is the occurrence of a disease or condition that alters 
health and quality of life. 
Mortality 
Death. Usually the cause (a specific disease, a condition, or an injury) is stated.  
Mutagen 
A substance that causes mutations (genetic damage).  
Mutation 
A change (damage) to the DNA, genes, or chromosomes of living organisms.  
National Priorities List for Uncontrolled Hazardous Waste Sites (National Priorities List or 
NPL) 
EPA's list of the most serious uncontrolled or abandoned hazardous waste sites in the United 
States. The NPL is updated on a regular basis. 
National Toxicology Program (NTP) 
Part of the Department of Health and Human Services. NTP develops and carries out tests to 
predict whether a chemical will cause harm to humans.  
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No apparent public health hazard  
A category used in ATSDR's public health assessments for sites where human exposure to 
contaminated media might be occurring, might have occurred in the past, or might occur in the 
future, but where the exposure is not expected to cause any harmful health effects.  
No-observed-adverse-effect level (NOAEL)  
The highest tested dose of a substance that has been reported to have no harmful (adverse) health 
effects on people or animals. 
No public health hazard 
A category used in ATSDR's public health assessment documents for sites where people have 
never and will never come into contact with harmful amounts of site-related substances.  
NPL [see National Priorities List for Uncontrolled Hazardous Waste Sites] 
Physiologically based pharmacokinetic model (PBPK model) 
A computer model that describes what happens to a chemical in the body. This model describes 
how the chemical gets into the body, where it goes in the body, how it is changed by the body, 
and how it leaves the body. 
Pica 
A craving to eat nonfood items, such as dirt, paint chips, and clay. Some children exhibit pica-
related behavior. 
Plume 
A volume of a substance that moves from its source to places farther away from the source. 
Plumes can be described by the volume of air or water they occupy and the direction they move. 
For example, a plume can be a column of smoke from a chimney or a substance moving with 
groundwater. 
Point of exposure  
The place where someone can come into contact with a substance present in the environment 
[see exposure pathway]. 
Population 
A group or number of people living within a specified area or sharing similar characteristics 
(such as occupation or age). 
Potentially responsible party (PRP)  
A company, government, or person legally responsible for cleaning up the pollution at a 
hazardous waste site under Superfund. There may be more than one PRP for a particular site.  
ppb 
Parts per billion. 
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ppm 
Parts per million.  
Prevalence 
The number of existing disease cases in a defined population during a specific time period 
[contrast with incidence]. 
Prevalence survey 
The measure of the current level of disease(s) or symptoms and exposures through a 
questionnaire that collects self-reported information from a defined population.  
Prevention 
Actions that reduce exposure or other risks, keep people from getting sick, or keep disease from 
getting worse. 
Public availability session  
An informal, drop-by meeting at which community members can meet one-on-one with ATSDR 
staff members to discuss health and site-related concerns. 
Public comment period 
An opportunity for the public to comment on agency findings or proposed activities contained in 
draft reports or documents. The public comment period is a limited time period during which 
comments will be accepted.  
Public health action 
A list of steps to protect public health. 
Public health advisory 
A statement made by ATSDR to EPA or a state regulatory agency that a release of hazardous 
substances poses an immediate threat to human health. The advisory includes recommended 
measures to reduce exposure and reduce the threat to human health.  
Public health assessment (PHA) 
An ATSDR document that examines hazardous substances, health outcomes, and community 
concerns at a hazardous waste site to determine whether people could be harmed from coming 
into contact with those substances. The PHA also lists actions that need to be taken to protect 
public health [compare with health consultation].  
Public health hazard  
A category used in ATSDR's public health assessments for sites that pose a public health hazard 
because of long-term exposures (greater than 1 year) to sufficiently high levels of hazardous 
substances or radionuclides that could result in harmful health effects.  
Public health hazard categories  
Public health hazard categories are statements about whether people could be harmed by 
conditions present at the site in the past, present, or future. One or more hazard categories might 
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be appropriate for each site. The five public health hazard categories are no public health hazard, 
no apparent public health hazard, indeterminate public health hazard, public health hazard, and 
urgent public health hazard. 
Public health statement 
The first chapter of an ATSDR toxicological profile. The public health statement is a summary 
written in words that are easy to understand. The public health statement explains how people 
might be exposed to a specific substance and describes the known health effects of that 
substance. 
Public health surveillance 
The ongoing, systematic collection, analysis, and interpretation of health data. This activity also 
involves timely dissemination of the data and use for public health programs. 
Public meeting  
A public forum with community members for communication about a site.  
Radioisotope 
An unstable or radioactive isotope (form) of an element that can change into another element by 
giving off radiation. 
Radionuclide 
Any radioactive isotope (form) of any element.  
RCRA [see Resource Conservation and Recovery Act (1976, 1984)]  
Receptor population 
People who could come into contact with hazardous substances [see exposure pathway].  
Reference dose (RfD)  
An EPA estimate, with uncertainty or safety factors built in, of the daily lifetime dose of a 
substance that is unlikely to cause harm in humans.  
Registry 
A systematic collection of information on persons exposed to a specific substance or having 
specific diseases [see exposure registry and disease registry].  
Remedial investigation 
The CERCLA process of determining the type and extent of hazardous material contamination at 
a site. 
Resource Conservation and Recovery Act (1976, 1984) (RCRA) 
This Act regulates management and disposal of hazardous wastes currently generated, treated, 
stored, disposed of, or distributed. 
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RFA 
RCRA Facility Assessment. An assessment required by RCRA to identify potential and actual 
releases of hazardous chemicals.  
RfD [see reference dose] 
Risk 
The probability that something will cause injury or harm.  
Risk reduction 
Actions that can decrease the likelihood that individuals, groups, or communities will experience 
disease or other health conditions. 
Risk communication 
The exchange of information to increase understanding of health risks.  
Route of exposure  
The way people come into contact with a hazardous substance. Three routes of exposure are 
breathing [inhalation], eating or drinking [ingestion], or contact with the skin [dermal contact].  
Safety factor [see uncertainty factor]  
SARA [see Superfund Amendments and Reauthorization Act]  
Sample 
A portion or piece of a whole. A selected subset of a population or subset of whatever is being 
studied. For example, in a study of people the sample is a number of people chosen from a larger 
population [see population]. An environmental sample (for example, a small amount of soil or 
water) might be collected to measure contamination in the environment at a specific location.  
Sample size 
The number of units chosen from a population or an environment.  
Solvent 
A liquid capable of dissolving or dispersing another substance (for example, acetone or mineral 
spirits). 
Source of contamination 
The place where a hazardous substance comes from, such as a landfill, waste pond, incinerator, 
storage tank, or drum. A source of contamination is the first part of an exposure pathway.  
Special populations 
People who might be more sensitive or susceptible to exposure to hazardous substances because 
of factors such as age, occupation, sex, or behaviors (for example, cigarette smoking). Children, 
pregnant women, and older people are often considered special populations.  
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Stakeholder 
A person, group, or community who has an interest in activities at a hazardous waste site.  
Statistics 
A branch of mathematics that deals with collecting, reviewing, summarizing, and interpreting 
data or information. Statistics are used to determine whether differences between study groups 
are meaningful.  
Substance 
A chemical.  
Substance-specific applied research 
A program of research designed to fill important data needs for specific hazardous substances 
identified in ATSDR's toxicological profiles. Filling these data needs would allow more accurate 
assessment of human risks from specific substances contaminating the environment. This 
research might include human studies or laboratory experiments to determine health effects 
resulting from exposure to a given hazardous substance.  
Superfund [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980 (CERCLA) and Superfund Amendments and Reauthorization Act (SARA)  
Superfund Amendments and Reauthorization Act (SARA)  
In 1986, SARA amended the Comprehensive Environmental Response, Compensation, and 
Liability Act of 1980 (CERCLA) and expanded the health-related responsibilities of ATSDR. 
CERCLA and SARA direct ATSDR to look into the health effects from substance exposures at 
hazardous waste sites and to perform activities including health education, health studies, 
surveillance, health consultations, and toxicological profiles.  
Surface water  
Water on the surface of the earth, such as in lakes, rivers, streams, ponds, and springs [compare 
with groundwater]. 
Surveillance [see public health surveillance]  
Survey 
A systematic collection of information or data. A survey can be conducted to collect information 
from a group of people or from the environment. Surveys of a group of people can be conducted 
by telephone, by mail, or in person. Some surveys are done by interviewing a group of people 
[see prevalence survey]. 
Synergistic effect 
A biologic response to multiple substances where one substance worsens the effect of another 
substance. The combined effect of the substances acting together is greater than the sum of the 
effects of the substances acting by themselves [see additive effect and antagonistic effect].  
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Teratogen 
A substance that causes defects in development between conception and birth. A teratogen is a 
substance that causes a structural or functional birth defect.  
Toxic agent 
Chemical or physical (for example, radiation, heat, cold, microwaves) agents that, under certain 
circumstances of exposure, can cause harmful effects to living organisms.  
Toxicological profile 
An ATSDR document that examines, summarizes, and interprets information about a hazardous 
substance to determine harmful levels of exposure and associated health effects. A toxicological 
profile also identifies significant gaps in knowledge on the substance and describes areas where 
further research is needed. 
Toxicology 
The study of the harmful effects of substances on humans or animals.  
Tumor 
An abnormal mass of tissue that results from excessive cell division that is uncontrolled and 
progressive. Tumors perform no useful body function. Tumors can be either benign (not cancer) 
or malignant (cancer).  
Uncertainty factor  
Mathematical adjustments for reasons of safety when knowledge is incomplete. For example, 
factors used in the calculation of doses that are not harmful (adverse) to people. These factors are 
applied to the lowest-observed-adverse-effect-level (LOAEL) or the no-observed-adverse-effect­
level (NOAEL) to derive a minimal risk level (MRL). Uncertainty factors are used to account for 
variations in people's sensitivity, for differences between animals and humans, and for 
differences between a LOAEL and a NOAEL. Scientists use uncertainty factors when they have 
some, but not all, the information from animal or human studies to decide whether an exposure 
will cause harm to people [also sometimes called a safety factor]. 
Urgent public health hazard  
A category used in ATSDR's public health assessments for sites where short-term exposures 
(less than 1 year) to hazardous substances or conditions could result in harmful health effects that 
require rapid intervention. 
Volatile organic compounds (VOCs) 
Organic compounds that evaporate readily into the air. VOCs include substances such as 
 
benzene, toluene, methylene chloride, and methyl chloroform.  
 
Other glossaries and dictionaries: 
 
Environmental Protection Agency (http://www.epa.gov/OCEPAterms/) 
 
National Center for Environmental Health (CDC) 

(http://www.cdc.gov/nceh/dls/report/glossary.htm) 
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National Library of Medicine (NIH) 
(http://www.nlm.nih.gov/medlineplus/mplusdictionary.html) 
For more information on the work of ATSDR, please contact: 
Office of Policy and External Affairs 
 
Agency for Toxic Substances and Disease Registry 
 
1600 Clifton Road, N.E. (MS E-60) 
 
Atlanta, GA 30333 
 
Telephone: (404) 498-0080 
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